<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
    <journal-title-group>
      <journal-title>Nature Communications</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2041-1723</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9992663</article-id>
    <article-id pub-id-type="pmid">36882394</article-id>
    <article-id pub-id-type="publisher-id">36862</article-id>
    <article-id pub-id-type="doi">10.1038/s41467-023-36862-w</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>OTTERS: a powerful TWAS framework leveraging summary-level reference data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Dai</surname>
          <given-names>Qile</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Geyu</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1195-9607</contrib-id>
        <name>
          <surname>Zhao</surname>
          <given-names>Hongyu</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3476-1652</contrib-id>
        <name>
          <surname>Võsa</surname>
          <given-names>Urmo</given-names>
        </name>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5159-8802</contrib-id>
        <name>
          <surname>Franke</surname>
          <given-names>Lude</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5287-627X</contrib-id>
        <name>
          <surname>Battle</surname>
          <given-names>Alexis</given-names>
        </name>
        <xref ref-type="aff" rid="Aff8">8</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8309-094X</contrib-id>
        <name>
          <surname>Teumer</surname>
          <given-names>Alexander</given-names>
        </name>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2555-4427</contrib-id>
        <name>
          <surname>Lehtimäki</surname>
          <given-names>Terho</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Raitakari</surname>
          <given-names>Olli T.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff11">11</xref>
        <xref ref-type="aff" rid="Aff12">12</xref>
        <xref ref-type="aff" rid="Aff13">13</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Esko</surname>
          <given-names>Tõnu</given-names>
        </name>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author" id="IAu1">
        <collab>eQTLGen Consortium<contrib-group><contrib contrib-type="author"><name><surname>Agbessi</surname><given-names>Mawussé</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Ahsan</surname><given-names>Habibul</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Alves</surname><given-names>Isabel</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Andiappan</surname><given-names>Anand Kumar</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Arindrarto</surname><given-names>Wibowo</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Awadalla</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Battle</surname><given-names>Alexis</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Beutner</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Jan Bonder</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Boomsma</surname><given-names>Dorret I.</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Christiansen</surname><given-names>Mark W.</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Claringbould</surname><given-names>Annique</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Deelen</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff22">22</xref><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Favé</surname><given-names>Marie-Julie</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Frayling</surname><given-names>Timothy</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Gharib</surname><given-names>Sina A.</given-names></name><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Gibson</surname><given-names>Greg</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Heijmans</surname><given-names>Bastiaan T.</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Hemani</surname><given-names>Gibran</given-names></name><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Jansen</surname><given-names>Rick</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Kähönen</surname><given-names>Mika</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author"><name><surname>Kalnapenkis</surname><given-names>Anette</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kasela</surname><given-names>Silva</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kettunen</surname><given-names>Johannes</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Yungil</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Kirsten</surname><given-names>Holger</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name><surname>Kovacs</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Krohn</surname><given-names>Knut</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name><surname>Kronberg</surname><given-names>Jaanika</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kukushkina</surname><given-names>Viktorija</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kutalik</surname><given-names>Zoltan</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Bernett</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Loeffler</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name><surname>Marigorta</surname><given-names>Urko M.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff36">36</xref><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name><surname>Mei</surname><given-names>Hailang</given-names></name><xref ref-type="aff" rid="Aff38">38</xref></contrib><contrib contrib-type="author"><name><surname>Milani</surname><given-names>Lili</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Montgomery</surname><given-names>Grant W.</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>Müller-Nurasyid</surname><given-names>Martina</given-names></name><xref ref-type="aff" rid="Aff40">40</xref><xref ref-type="aff" rid="Aff41">41</xref><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name><surname>Nauck</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="Aff43">43</xref><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>Nivard</surname><given-names>Michel G.</given-names></name><xref ref-type="aff" rid="Aff45">45</xref></contrib><contrib contrib-type="author"><name><surname>Penninx</surname><given-names>Brenda</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Perola</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><contrib contrib-type="author"><name><surname>Pervjakova</surname><given-names>Natalia</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Pierce</surname><given-names>Brandon L.</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Powell</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name><surname>Prokisch</surname><given-names>Holger</given-names></name><xref ref-type="aff" rid="Aff48">48</xref><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><name><surname>Psaty</surname><given-names>Bruce M.</given-names></name><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff50">50</xref></contrib><contrib contrib-type="author"><name><surname>Ripatti</surname><given-names>Samuli</given-names></name><xref ref-type="aff" rid="Aff51">51</xref></contrib><contrib contrib-type="author"><name><surname>Rotzschke</surname><given-names>Olaf</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Rüeger</surname><given-names>Sina</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name><surname>Saha</surname><given-names>Ashis</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Scholz</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name><surname>Schramm</surname><given-names>Katharina</given-names></name><xref ref-type="aff" rid="Aff40">40</xref><xref ref-type="aff" rid="Aff41">41</xref></contrib><contrib contrib-type="author"><name><surname>Seppälä</surname><given-names>Ilkka</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Slagboom</surname><given-names>Eline P.</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Stehouwer</surname><given-names>Coen D. A.</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name><surname>Stumvoll</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name><surname>Sullivan</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><contrib contrib-type="author"><name><surname>‘t Hoen</surname><given-names>Peter A. C.</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><contrib contrib-type="author"><name><surname>Thiery</surname><given-names>Joachim</given-names></name><xref ref-type="aff" rid="Aff56">56</xref></contrib><contrib contrib-type="author"><name><surname>Tong</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Tönjes</surname><given-names>Anke</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>van Dongen</surname><given-names>Jenny</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>van Iterson</surname><given-names>Maarten</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>van Meurs</surname><given-names>Joyce</given-names></name><xref ref-type="aff" rid="Aff57">57</xref></contrib><contrib contrib-type="author"><name><surname>Veldink</surname><given-names>Jan H.</given-names></name><xref ref-type="aff" rid="Aff58">58</xref></contrib><contrib contrib-type="author"><name><surname>Verlouw</surname><given-names>Joost</given-names></name><xref ref-type="aff" rid="Aff57">57</xref></contrib><contrib contrib-type="author"><name><surname>Visscher</surname><given-names>Peter M.</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>Völker</surname><given-names>Uwe</given-names></name><xref ref-type="aff" rid="Aff59">59</xref></contrib><contrib contrib-type="author"><name><surname>Westra</surname><given-names>Harm-Jan</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Wijmenga</surname><given-names>Cisca</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Yaghootka</surname><given-names>Hanieh</given-names></name><xref ref-type="aff" rid="Aff24">24</xref><xref ref-type="aff" rid="Aff60">60</xref><xref ref-type="aff" rid="Aff61">61</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="Aff39">39</xref><xref ref-type="aff" rid="Aff62">62</xref></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Biao</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Futao</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib></contrib-group></collab>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9647-9738</contrib-id>
        <name>
          <surname>Epstein</surname>
          <given-names>Michael P.</given-names>
        </name>
        <address>
          <email>mpepste@emory.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4191-4138</contrib-id>
        <name>
          <surname>Yang</surname>
          <given-names>Jingjing</given-names>
        </name>
        <address>
          <email>jingjing.yang@emory.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.189967.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 6502</institution-id><institution>Department of Biostatistics and Bioinformatics, </institution><institution>Emory University School of Public Health, </institution></institution-wrap>Atlanta, GA 30322 USA </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.189967.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 6502</institution-id><institution>Center for Computational and Quantitative Genetics, Department of Human Genetics, </institution><institution>Emory University School of Medicine, </institution></institution-wrap>Atlanta, GA 30322 USA </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Program of Computational Biology and Bioinformatics, </institution><institution>Yale University, </institution></institution-wrap>New Haven, CT 06511 USA </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Biostatistics, </institution><institution>Yale School of Public Health, </institution></institution-wrap>New Haven, CT 06520 USA </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.10939.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 0943 7661</institution-id><institution>Estonian Genome Centre, Institute of Genomics, </institution><institution>University of Tartu, </institution></institution-wrap>50090 Tartu, Estonia </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.4494.d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9558 4598</institution-id><institution>Department of Genetics, University of Groningen, </institution><institution>University Medical Center Groningen, </institution></institution-wrap>9700 RB Groningen, The Netherlands </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.499559.d</institution-id><institution>Oncode Institute, </institution></institution-wrap>3521 AL Utrecht, The Netherlands </aff>
      <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Department of Computer Science, and Departments of Biomedical Engineering, </institution><institution>Johns Hopkins University, </institution></institution-wrap>Baltimore, MD 21218 USA </aff>
      <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.5603.0</institution-id><institution>Institute for Community Medicine, </institution><institution>University Medicine Greifswald, </institution></institution-wrap>17489 Greifswald, Germany </aff>
      <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.502801.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2314 6254</institution-id><institution>Department of Clinical Chemistry, Fimlab Laboratories and Finnish Centre for Cardiovascular Disease Tampere, Faculty of Medicine and Health Technology, </institution><institution>Tampere University, </institution></institution-wrap>Tampere, 33520 Finland </aff>
      <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.1374.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 1371</institution-id><institution>Centre for Population Health Research, </institution><institution>University of Turku and Turku University Hospital, </institution></institution-wrap>20520 Turku, Finland </aff>
      <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.1374.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 1371</institution-id><institution>Research Centre of Applied and Preventive Cardiovascular Medicine, </institution><institution>University of Turku, </institution></institution-wrap>20520 Turku, Finland </aff>
      <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.410552.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 215X</institution-id><institution>Department of Clinical Physiology and Nuclear Medicine, </institution><institution>Turku University Hospital, </institution></institution-wrap>20521 Turku, Finland </aff>
      <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.419890.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0626 690X</institution-id><institution>Computational Biology, </institution><institution>Ontario Institute for Cancer Research, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.170205.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7822</institution-id><institution>Department of Public Health Sciences, </institution><institution>University of Chicago, </institution></institution-wrap>Chicago, IL USA </aff>
      <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.430276.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0387 2429</institution-id><institution>Singapore Immunology Network, Agency for Science Technology and Research, </institution></institution-wrap>Singapore, Singapore </aff>
      <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution-id institution-id-type="ISNI">0000000089452978</institution-id><institution>Leiden University Medical Center, </institution></institution-wrap>Leiden, The Netherlands </aff>
      <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Heart Center Leipzig, </institution><institution>Universität Leipzig, </institution></institution-wrap>Leipzig, Germany </aff>
      <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.4709.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0495 846X</institution-id><institution>European Molecular Biology Laboratory, Genome Biology Unit, </institution></institution-wrap>69117 Heidelberg, Germany </aff>
      <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.12380.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1754 9227</institution-id><institution>Department of Biological Psychology, </institution><institution>Vrije Universiteit Amsterdam, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
      <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Cardiovascular Health Research Unit, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff>
      <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.4494.d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9558 4598</institution-id><institution>Genomics Coordination Center, </institution><institution>University Medical Centre Groningen, </institution></institution-wrap>Groningen, The Netherlands </aff>
      <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.7692.a</institution-id><institution-id institution-id-type="ISNI">0000000090126352</institution-id><institution>Department of Genetics, </institution><institution>University Medical Centre Utrecht, </institution></institution-wrap>P.O. Box 85500, 3508 GA Utrecht, The Netherlands </aff>
      <aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.8391.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8024</institution-id><institution>Genetics of Complex Traits, </institution><institution>University of Exeter Medical School, Royal Devon &amp; Exeter Hospital, </institution></institution-wrap>Exeter, UK </aff>
      <aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Department of Medicine, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff>
      <aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.213917.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 4943</institution-id><institution>School of Biological Sciences, </institution><institution>Georgia Tech, </institution></institution-wrap>Atlanta, GA USA </aff>
      <aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.5337.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7603</institution-id><institution>MRC Integrative Epidemiology Unit, </institution><institution>University of Bristol, </institution></institution-wrap>Bristol, UK </aff>
      <aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.12380.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1754 9227</institution-id><institution>Amsterdam UMC, </institution><institution>Vrije Universiteit Amsterdam, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
      <aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.502801.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2314 6254</institution-id><institution>Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Health Technology, </institution><institution>Tampere University, </institution></institution-wrap>Tampere, Finland </aff>
      <aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution>University of Helsinki, </institution></institution-wrap>Helsinki, Finland </aff>
      <aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Genetics and Genomic Science Department, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
      <aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Institut für Medizinische InformatiK, Statistik und Epidemiologie, LIFE – Leipzig Research Center for Civilization Diseases, </institution><institution>Universität Leipzig, </institution></institution-wrap>Leipzig, Germany </aff>
      <aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>IFB Adiposity Diseases, </institution><institution>Universität Leipzig, </institution></institution-wrap>Leipzig, Germany </aff>
      <aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Interdisciplinary Center for Clinical Research, Faculty of Medicine, </institution><institution>Universität Leipzig, </institution></institution-wrap>Leipzig, Germany </aff>
      <aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="GRID">grid.8515.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 0423 4662</institution-id><institution>Lausanne University Hospital, </institution></institution-wrap>Lausanne, Switzerland </aff>
      <aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="GRID">grid.420161.0</institution-id><institution>Integrative Genomics Lab, CIC bioGUNE, </institution><institution>Bizkaia Science and Technology Park, </institution></institution-wrap>Derio, Bizkaia, Basque Country Spain </aff>
      <aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.424810.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0467 2314</institution-id><institution>IKERBASQUE, </institution><institution>Basque Foundation for Science, </institution></institution-wrap>Bilbao, Spain </aff>
      <aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution-id institution-id-type="ISNI">0000000089452978</institution-id><institution>Department of Medical Statistics and Bioinformatics, </institution><institution>Leiden University Medical Center, </institution></institution-wrap>Leiden, The Netherlands </aff>
      <aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>Institute for Molecular Bioscience, </institution><institution>University of Queensland, </institution></institution-wrap>Brisbane, QLD Australia </aff>
      <aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="GRID">grid.4567.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0483 2525</institution-id><institution>Institute of Genetic Epidemiology, </institution><institution>Helmholtz Zentrum München – German Research Center for Environmental Health, </institution></institution-wrap>Neuherberg, Germany </aff>
      <aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="GRID">grid.5252.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 973X</institution-id><institution>Department of Medicine I, </institution><institution>University Hospital Munich, Ludwig Maximilian’s University, </institution></institution-wrap>München, Germany </aff>
      <aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="GRID">grid.452396.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 5937 5237</institution-id><institution>DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, </institution></institution-wrap>Munich, Germany </aff>
      <aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="GRID">grid.412469.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9116 8976</institution-id><institution>Institute of Clinical Chemistry and Laboratory Medicine, Greifswald University Hospital, </institution></institution-wrap>Greifswald, Germany </aff>
      <aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="GRID">grid.452396.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 5937 5237</institution-id><institution>German Center for Cardiovascular Research (partner site Greifswald), </institution></institution-wrap>Greifswald, Germany </aff>
      <aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="GRID">grid.12380.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1754 9227</institution-id><institution>Department of Biological Psychology, Faculty of Behaviour and Movement Sciences, </institution><institution>VU, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
      <aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution>National Institute for Health and Welfare, University of Helsinki, </institution></institution-wrap>Helsinki, Finland </aff>
      <aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="GRID">grid.415306.5</institution-id><institution-id institution-id-type="ISNI">0000 0000 9983 6924</institution-id><institution>Garvan Institute of Medical Research, Garvan-Weizmann Centre for Cellular Genomics, </institution></institution-wrap>Sydney, NSW Australia </aff>
      <aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="GRID">grid.4567.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0483 2525</institution-id><institution>Institute of Neurogenomics, Helmholtz Zentrum München, </institution></institution-wrap>Neuherberg, Germany </aff>
      <aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="GRID">grid.6936.a</institution-id><institution-id institution-id-type="ISNI">0000000123222966</institution-id><institution>Institute of Human Genetics, </institution><institution>Technical University Munich, </institution></institution-wrap>Munich, Germany </aff>
      <aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="GRID">grid.488833.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0615 7519</institution-id><institution>Kaiser Permanente Washington Health Research Institute, </institution></institution-wrap>Seattle, WA USA </aff>
      <aff id="Aff51"><label>51</label><institution-wrap><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution>Statistical and Translational Genetics, </institution><institution>University of Helsinki, </institution></institution-wrap>Helsinki, Finland </aff>
      <aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="GRID">grid.412966.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0480 1382</institution-id><institution>Department of Internal Medicine and School for Cardiovascular Diseases (CARIM), </institution><institution>Maastricht University Medical Center, </institution></institution-wrap>Maastricht, The Netherlands </aff>
      <aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Department of Medicine, </institution><institution>Universität Leipzig, </institution></institution-wrap>Leipzig, Germany </aff>
      <aff id="Aff54"><label>54</label><institution-wrap><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Department of Medical Epidemiology and Biostatistics, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
      <aff id="Aff55"><label>55</label><institution-wrap><institution-id institution-id-type="GRID">grid.10417.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0444 9382</institution-id><institution>Center for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, </institution><institution>Radboud University Medical Center Nijmegen, </institution></institution-wrap>Nijmegen, The Netherlands </aff>
      <aff id="Aff56"><label>56</label><institution-wrap><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Institute for Laboratory Medicine, LIFE – Leipzig Research Center for Civilization Diseases, </institution><institution>Universität Leipzig, </institution></institution-wrap>Leipzig, Germany </aff>
      <aff id="Aff57"><label>57</label><institution-wrap><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution-id institution-id-type="ISNI">000000040459992X</institution-id><institution>Department of Internal Medicine, </institution><institution>Erasmus Medical Centre, </institution></institution-wrap>Rotterdam, The Netherlands </aff>
      <aff id="Aff58"><label>58</label><institution-wrap><institution-id institution-id-type="GRID">grid.5477.1</institution-id><institution-id institution-id-type="ISNI">0000000120346234</institution-id><institution>UMC Utrecht Brain Center, University Medical Center Utrecht, Department of Neurology, </institution><institution>Utrecht University, </institution></institution-wrap>Utrecht, The Netherlands </aff>
      <aff id="Aff59"><label>59</label><institution-wrap><institution-id institution-id-type="GRID">grid.5603.0</institution-id><institution>Interfaculty Institute for Genetics and Functional Genomics, </institution><institution>University Medicine Greifswald, </institution></institution-wrap>Greifswald, Germany </aff>
      <aff id="Aff60"><label>60</label><institution-wrap><institution-id institution-id-type="GRID">grid.12896.34</institution-id><institution-id institution-id-type="ISNI">0000 0000 9046 8598</institution-id><institution>School of Life Sciences, College of Liberal Arts and Science, </institution><institution>University of Westminster, </institution></institution-wrap>115 New Cavendish Street, London, UK </aff>
      <aff id="Aff61"><label>61</label><institution-wrap><institution-id institution-id-type="GRID">grid.6926.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 1014 8699</institution-id><institution>Division of Medical Sciences, Department of Health Sciences, </institution><institution>Luleå University of Technology, </institution></institution-wrap>Luleå, Sweden </aff>
      <aff id="Aff62"><label>62</label><institution-wrap><institution-id institution-id-type="GRID">grid.494629.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 8008 9315</institution-id><institution>School of Life Sciences, </institution><institution>Westlake University, </institution></institution-wrap>Hangzhou, Zhejiang China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>7</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>7</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>14</volume>
    <elocation-id>1271</elocation-id>
    <history>
      <date date-type="received">
        <day>7</day>
        <month>7</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>20</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">Most existing TWAS tools require individual-level eQTL reference data and thus are not applicable to summary-level reference eQTL datasets. The development of TWAS methods that can harness summary-level reference data is valuable to enable TWAS in broader settings and enhance power due to increased reference sample size. Thus, we develop a TWAS framework called OTTERS (Omnibus Transcriptome Test using Expression Reference Summary data) that adapts multiple polygenic risk score (PRS) methods to estimate eQTL weights from summary-level eQTL reference data and conducts an omnibus TWAS. We show that OTTERS is a practical and powerful TWAS tool by both simulations and application studies.</p>
    </abstract>
    <abstract id="Abs2" abstract-type="web-summary">
      <p id="Par2">Here, the authors present a TWAS framework OTTERS that adapts multiple polygenic risk score methods to estimate eQTL weights from summary-level eQTL data. Both simulation and real studies show OTTERS is powerful across a wide range of genetic architectures.</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Genetic association study</kwd>
      <kwd>Gene expression</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002301</institution-id>
            <institution>Eesti Teadusagentuur (Estonian Research Council)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>PRG1291</award-id>
        <principal-award-recipient>
          <name>
            <surname>Esko</surname>
            <given-names>Tõnu</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000049</institution-id>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>RF1AG071170</award-id>
        <principal-award-recipient>
          <name>
            <surname>Epstein</surname>
            <given-names>Michael P.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000057</institution-id>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>R35GM138313</award-id>
        <principal-award-recipient>
          <name>
            <surname>Yang</surname>
            <given-names>Jingjing</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1" sec-type="introduction">
    <title>Introduction</title>
    <p id="Par3">Transcriptome-wide association study (TWAS) is a valuable analysis strategy for identifying genes that influence complex traits and diseases through genetic regulation of gene expression<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR5">5</xref></sup>. Researchers have successfully deployed TWAS analyses to identify risk genes for complex human diseases, including Alzheimer’s disease<sup><xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref></sup>, breast cancer<sup><xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref></sup>, ovarian cancer<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>, and cardiovascular disease<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>. A typical TWAS consists of two separate stages. In Stage I, TWAS acquires individual-level genetic and expression data from relevant tissues available in a reference dataset like the Genotype-Tissue Expression (GTEx) project<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup> or the North American Brain Expression Consortium<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, and trains multivariable regression models on the reference data treating gene expression as outcome and SNP genotype data (typically cis-SNPs nearby the test gene) as predictors to determine genetically regulated expression (GReX). After Stage I that uses the GReX regression models to estimate effect sizes of SNP predictors that, in the broad sense, are effect sizes of expression quantitative trait loci (eQTLs), Stage II of TWAS proceeds by using these trained eQTL effect sizes to impute GReX within an independent GWAS of a complex human disease or trait. One can then test for association between the imputed GReX and phenotype, which is equivalent to a gene-based association test taking these eQTL effect sizes as corresponding test SNP weights<sup><xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref></sup>.</p>
    <p id="Par4">For Stage I of TWAS, a variety of training tools exist for fitting GReX regression models using reference expression and genetic data, including PrediXcan<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, FUSION<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, and TIGAR<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. While these methods all employ different techniques for model fitting, they all require individual-level reference expression and genetic data to estimate eQTL effect sizes for TWAS. Therefore, these methods cannot be applied to emerging reference summary-level eQTL results such as those generated by the eQTLGen<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and CommonMind<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> consortia, which provide eQTL effect sizes and <italic>p</italic> values relating individual SNPs to gene expression. The development of TWAS methods that can utilize such summary-level reference data is valuable to permit the applicability of the technique to broader analysis settings. Moreover, as TWAS power increases with increasing reference sample size<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, TWAS using summary-level reference datasets can lead to enhanced performance compared to using individual-level reference datasets since the sample sizes of the former often are considerably larger than the latter. For example, the sample size of the summary-based eQTLGen reference sample is 31,684 for blood, whereas the sample size of the individual-level GTEx V6 reference is only 338 for the same tissue. Consequently, TWAS analysis leveraging the summary-based eQTLGen dataset as a reference can likely provide insights into the genetic regulation of complex human traits.</p>
    <p id="Par5">In this work, we propose a framework that can use summary-level reference data to train GReX regression models required for Stage I of TWAS analysis. Our method is motivated by a variety of published polygenic risk score (PRS) methods<sup><xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR31">31</xref></sup> that can predict phenotype in a test dataset using summary-level SNP effect size estimates and <italic>p</italic> values based on single SNP tests from an independent reference GWAS. We can adapt these PRS methods for TWAS since eQTL effect sizes are essentially SNP effect sizes resulting from a reference “GWAS” of gene expression. Thus, our predicted GReX in Stage II of TWAS is analogous to the PRS constructed based on training GWAS summary statistics of single SNP-trait association. Here, we adapt four representative summary-data-based PRS methods—<italic>p</italic> value thresholding with linkage disequilibrium (LD) clumping (P+T)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, frequentist LASSO<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> regression-based method lassosum<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, nonparametric Bayesian Dirichlet Process Regression (DPR) model-based<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> method SDPR<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, and Bayesian multivariable regression model-based method with continuous shrinkage (CS) priors PRS-CS<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> for TWAS analysis. We apply each of these PRS methods to first train eQTL effect sizes based on a multivariable regression model from summary-level reference eQTL data (Stage I), and subsequently use these eQTL effect sizes (i.e., eQTL weights) to impute GReX and then test GReX-trait association in an independent test GWAS (Stage II).</p>
    <p id="Par6">As we will show, the PRS method with optimal performance for TWAS depends on the underlying genetic architecture for gene expression. Since the genetic architecture of expression is unknown apriori, we maximize the performance of TWAS over different possible architectures by proposing a TWAS framework called OTTERS (Omnibus Transcriptome Test using Expression Reference Summary data). OTTERS first constructs individual TWAS tests and <italic>p</italic> values using eQTL weights trained by each of the PRS techniques outlined above, and then calculates an omnibus test <italic>p</italic> value using the aggregated Cauchy association test<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> (ACAT-O) with all individual TWAS <italic>p</italic> values (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). OTTERS is applicable to both summary-level and individual-level test GWAS data within Stage II TWAS analysis.<fig id="Fig1"><label>Fig. 1</label><caption><title>OTTERS framework.</title><p>OTTERS estimates cis-eQTL weights from eQTL summary data and reference LD panel using four imputation models (Stage I), and conducts ACAT-O test to combine gene-based association test <italic>p</italic> values from individual methods with individual/summary-level test GWAS data (Stage II).</p></caption><graphic xlink:href="41467_2023_36862_Fig1_HTML" id="d32e1841"/></fig></p>
    <p id="Par7">In subsequent sections, we first describe how to use the PRS methods on summary-level reference eQTL data in Stage I TWAS, and then describe how we can use the resulting eQTL weights to perform Stage II TWAS using OTTERS. We then evaluate the performance of individual PRS methods and OTTERS using simulated expression and real genetic data based on patterns observed in real datasets. Interestingly, when we assume individual-level reference data are available, we observe that OTTERS outperforms the popular FUSION<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> approach across all simulation settings considered. Many of the individual PRS methods also outperform FUSION in these settings. We then apply OTTERS to blood eQTL summary-level data (<italic>n</italic> = 31,684) from the eQTLGen consortium<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and GWAS summary data of cardiovascular disease from the UK Biobank (UKBB)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. By comparing OTTERS results to those of FUSION<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> using individual-level GTEx reference data of whole blood tissue, we demonstrate that OTTERS using large summary-level reference datasets and multiple gene expression imputation models can successfully reveal potential risk genes missed by FUSION based on smaller individual-level reference datasets and only one model. Finally, we conclude with a discussion.</p>
  </sec>
  <sec id="Sec2" sec-type="results">
    <title>Results</title>
    <sec id="Sec3">
      <title>Method overview</title>
      <p id="Par8">For the standard two-stage TWAS approach, Stage I estimates a GReX imputation model using individual-level expression and genotype data available from a reference dataset, and then Stage II uses the eQTL effect sizes from Stage I to impute gene expression (GReX) in an independent GWAS and test for association between GReX and phenotype. GReX for test samples can be imputed from individual-level genotype data and eQTL effect size estimates. When individual-level GWAS data are not available, one can instead use summary-level GWAS data for TWAS by applying the TWAS <italic>Z</italic>-score statistics proposed by FUSION<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> and S-PrediXcan<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> (see details in Methods).</p>
      <p id="Par9">Since eQTL summary data are analogous to GWAS summary data where gene expression represents the phenotype, we can follow the idea from PRS methods to estimate the eQTL effect sizes based on a multivariable regression model using only marginal least squared effect estimates and <italic>p</italic> values (based on a single variant test) from the eQTL summary data as well as a reference LD panel from samples of the same ancestry<sup><xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR29">29</xref></sup>. Although all PRS methods are applicable to TWAS Stage I, we only consider four representative methods—P+T<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, Frequentist lassosum<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, Nonparametric Bayesian SDPR<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, Bayesian PRS-CS<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> (see details in Methods).</p>
      <p id="Par10">As shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>, OTTERS first trains GReX imputation models per gene <italic>g</italic> using P+T, lassosum, SDPR, and PRS-CS methods that each infers cis-eQTL weights using cis-eQTL summary data and an external LD reference panel of the same ancestry (Stage I). Once we derive cis-eQTL weights for each training method, we can impute the respective GReX using that method and perform the respective gene-based association analysis in the test GWAS dataset. We thus derive a set of TWAS <italic>p</italic> values for gene <italic>g</italic>, one per training method. We then use these TWAS <italic>p</italic> values to create an omnibus test using the ACAT-O<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> approach that employs a Cauchy distribution for inference (see details in Supplementary Methods). We refer to the <italic>p</italic> value derived from ACAT-O test as the OTTERS <italic>p</italic> value. The ACAT-O<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> approach has been widely used in hypothesis testing to combine multiple testing methods for the same hypothesis<sup><xref ref-type="bibr" rid="CR37">37</xref>–<xref ref-type="bibr" rid="CR39">39</xref></sup>, which has been shown as an effective approach to leverage different test methods to increase the power while still managing to control for type I error. Adding TWAS <italic>p</italic> values based on additional PRS methods to the ACAT-O test can possibly improve the power further at the cost of additional computation.</p>
    </sec>
    <sec id="Sec4">
      <title>Simulation study</title>
      <p id="Par11">We used real genotype data from 1894 whole-genome sequencing (WGS) samples from the Religious Orders Study and Rush Memory and Aging Project (ROS/MAP) cohort<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup> and Mount Sinai Brain Bank (MSBB) study<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> for simulation. We divided 14,772 genes into five groups according to gene length, and randomly selected 100 genes from each group (500 genes in total). We randomly split samples into 568 training (30%) and 1326 testing samples (70%) to mimic a relatively small sample size in the real reference panel for training gene expression imputation models. From the real genotype data, we simulated six scenarios with two different proportions of causal cis-eQTL, <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{{causal}}=$$\end{document}</tex-math><mml:math id="M2"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq1.gif"/></alternatives></inline-formula><inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left({{{{\mathrm{0.001,0.01}}}}}\right),$$\end{document}</tex-math><mml:math id="M4"><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">0.001, 0.01</mml:mi></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq2.gif"/></alternatives></inline-formula> as well as three different proportions of gene expression variance explained by causal eQTL, <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}=\left({{{{\mathrm{0.01,0.05,0.1}}}}}\right).$$\end{document}</tex-math><mml:math id="M6"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">0.01, 0.05, 0.1</mml:mi></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq3.gif"/></alternatives></inline-formula></p>
      <p id="Par12">We generated gene expression of gene <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$g$$\end{document}</tex-math><mml:math id="M8"><mml:mi>g</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq4.gif"/></alternatives></inline-formula> (<inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M10"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq5.gif"/></alternatives></inline-formula>) using the multivariable regression model <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}={{{{{{\bf{X}}}}}}}_{g}{{{{{\bf{w}}}}}}{{{{{\boldsymbol{+}}}}}}{{{{{{\boldsymbol{\epsilon }}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M12"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">w</mml:mi><mml:mi mathvariant="bold-italic">+</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq6.gif"/></alternatives></inline-formula>, where <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M14"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq7.gif"/></alternatives></inline-formula> represents the standardized genotype matrix of the randomly selected causal eQTL of gene <inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$g$$\end{document}</tex-math><mml:math id="M16"><mml:mi>g</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq8.gif"/></alternatives></inline-formula>, <inline-formula id="IEq9"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\boldsymbol{\epsilon }}}}}}}_{g}\sim N(0,(1-{h}_{e}^{2}){{{{{\bf{I}}}}}})$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi mathvariant="bold">I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq9.gif"/></alternatives></inline-formula>. We generated the eQTL effect sizes <inline-formula id="IEq10"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{w}}}}}}$$\end{document}</tex-math><mml:math id="M20"><mml:mi mathvariant="bold">w</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq10.gif"/></alternatives></inline-formula> from <inline-formula id="IEq11"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$N({{{{\mathrm{0,1}}}}})$$\end{document}</tex-math><mml:math id="M22"><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">0, 1</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq11.gif"/></alternatives></inline-formula> and then re-scaled these effects to ensure that the expression variance explained by all causal variants is <inline-formula id="IEq12"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}$$\end{document}</tex-math><mml:math id="M24"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq12.gif"/></alternatives></inline-formula>. We generated 10 replicates of gene expression per scenario. For each simulated gene expression, we then generated 10 sets of GWAS <italic>Z</italic>-scores to perform a total of 50,000 TWAS simulations. We generated the GWAS <italic>Z</italic>-scores from a multivariate normal distribution with <inline-formula id="IEq13"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{Z}}}}}}\sim {MVN}\left({{{{{{\mathbf{\Sigma }}}}}}}_{g}{{{{{\bf{w}}}}}}\sqrt{{n}_{{gwas}}{h}_{p}^{2}}{{,}}{{{{{{\mathbf{\Sigma }}}}}}}_{g}\right)$$\end{document}</tex-math><mml:math id="M26"><mml:mi mathvariant="bold">Z</mml:mi><mml:mo>~</mml:mo><mml:mi>M</mml:mi><mml:mi>V</mml:mi><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">Σ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">w</mml:mi><mml:msqrt><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:msqrt><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">Σ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq13.gif"/></alternatives></inline-formula><sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, where <inline-formula id="IEq14"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{w}}}}}}$$\end{document}</tex-math><mml:math id="M28"><mml:mi mathvariant="bold">w</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq14.gif"/></alternatives></inline-formula> is the true causal eQTL effect sizes, <inline-formula id="IEq15"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\mathbf{\Sigma }}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M30"><mml:msub><mml:mrow><mml:mi mathvariant="bold">Σ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq15.gif"/></alternatives></inline-formula> is the correlation matrix of the standardized genotype <inline-formula id="IEq16"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M32"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq16.gif"/></alternatives></inline-formula> from test samples, <inline-formula id="IEq17"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${n}_{{gwas}}$$\end{document}</tex-math><mml:math id="M34"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq17.gif"/></alternatives></inline-formula> is the assumed GWAS sample size, and <inline-formula id="IEq18"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{p}^{2}$$\end{document}</tex-math><mml:math id="M36"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq18.gif"/></alternatives></inline-formula> denotes the amount of phenotypic variance explained by simulated <inline-formula id="IEq19"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{GReX}}}}}}{{{{{\boldsymbol{=}}}}}}{{{{{\bf{X}}}}}}}_{g}{{{{{\bf{w}}}}}}$$\end{document}</tex-math><mml:math id="M38"><mml:msub><mml:mrow><mml:mi mathvariant="bold">GReX</mml:mi><mml:mi mathvariant="bold-italic">=</mml:mi><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">w</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq19.gif"/></alternatives></inline-formula> (see Methods). We set <inline-formula id="IEq20"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{p}^{2}=0.025$$\end{document}</tex-math><mml:math id="M40"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.025</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq20.gif"/></alternatives></inline-formula>. To calibrate power, we considered <inline-formula id="IEq21"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${n}_{{gwas}}$$\end{document}</tex-math><mml:math id="M42"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq21.gif"/></alternatives></inline-formula> = (200K, 300K, 400K, 500K) for scenarios with <inline-formula id="IEq22"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}$$\end{document}</tex-math><mml:math id="M44"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq22.gif"/></alternatives></inline-formula> = 0.01, <inline-formula id="IEq23"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${n}_{{gwas}}$$\end{document}</tex-math><mml:math id="M46"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq23.gif"/></alternatives></inline-formula> = (25K, 50K, 75K, 100K) for scenarios with <inline-formula id="IEq24"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}=0.05$$\end{document}</tex-math><mml:math id="M48"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.05</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq24.gif"/></alternatives></inline-formula>, and <inline-formula id="IEq25"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${n}_{{gwas}}$$\end{document}</tex-math><mml:math id="M50"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq25.gif"/></alternatives></inline-formula> = (10K, 20K, 30K, 40K) for scenarios with <inline-formula id="IEq26"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}=0.1$$\end{document}</tex-math><mml:math id="M52"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.1</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq26.gif"/></alternatives></inline-formula>.</p>
      <p id="Par13">In Stage I of our TWAS analysis, we applied P+T (0.001), P+T (0.05), lassosum, SDPR, and PRS-CS methods to estimate eQTL weights using eQTL summary data and the reference LD of training samples. In Stage II of the TWAS, we used the estimated eQTL weights and the simulated GWAS <italic>Z</italic>-scores to conduct a gene-based association test. In addition to gene-based association tests based on eQTL weights per training method, we further constructed the corresponding OTTERS <italic>p</italic> values. We evaluated the performance of the training methods with test samples, comparing test <inline-formula id="IEq27"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M54"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq27.gif"/></alternatives></inline-formula> that was the squared Pearson correlation coefficient between imputed GReX and simulated gene expression. We evaluated TWAS power given by the proportion of 50,000 repeated simulations with TWAS <italic>p</italic> value <inline-formula id="IEq28"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ &lt; 2.5\times {10}^{-6}$$\end{document}</tex-math><mml:math id="M56"><mml:mo>&lt;</mml:mo><mml:mn>2.5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq28.gif"/></alternatives></inline-formula> (genome-wide significance threshold adjusting for testing 20K independent genes).</p>
      <p id="Par14">As shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, we demonstrated that the Stage I training method with optimal test <inline-formula id="IEq29"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M58"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq29.gif"/></alternatives></inline-formula> and TWAS power depended on the underlying genetic architecture of gene expression (<inline-formula id="IEq30"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{{causal}}$$\end{document}</tex-math><mml:math id="M60"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq30.gif"/></alternatives></inline-formula>) as well as gene expression heritability (<inline-formula id="IEq31"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}$$\end{document}</tex-math><mml:math id="M62"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq31.gif"/></alternatives></inline-formula>). In situations where true cis-eQTLs were sparse (<inline-formula id="IEq32"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{{causal}}$$\end{document}</tex-math><mml:math id="M64"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq32.gif"/></alternatives></inline-formula> = 0.001) and the gene expression heritability was small (<inline-formula id="IEq33"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}$$\end{document}</tex-math><mml:math id="M66"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq33.gif"/></alternatives></inline-formula> = 0.01), P+T (0.05) method performed the best with the highest TWAS power among all individual methods. When gene expression heritability is low (<inline-formula id="IEq34"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}$$\end{document}</tex-math><mml:math id="M68"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq34.gif"/></alternatives></inline-formula> = 0.01), the power of P+T (0.001) and lassosum methods were shown as the lowest. When gene expression heritability increased (<inline-formula id="IEq35"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}$$\end{document}</tex-math><mml:math id="M70"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq35.gif"/></alternatives></inline-formula> = 0.05 or 0.1) within this sparse eQTL model, P+T (0.001) and PRS-CS were generally the optimal methods. For a less sparse model with <inline-formula id="IEq36"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{{causal}}$$\end{document}</tex-math><mml:math id="M72"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq36.gif"/></alternatives></inline-formula> = 0.01, SDPR and PRS-CS generally performed best among the individual methods. Relative to individual methods, we found that combining the TWAS <italic>p</italic> values based on the four PRS training methods together for analysis in our OTTERS framework obtained the highest power across all scenarios.<fig id="Fig2"><label>Fig. 2</label><caption><title>Test <italic>R</italic><sup>2</sup> (A) and TWAS power (B) comparison in simulation studies.</title><p>Various scenarios with proportions of true causal cis-eQTL <inline-formula id="IEq37"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{{causal}}=\left(0.001,0.01\right)$$\end{document}</tex-math><mml:math id="M74"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>0.001</mml:mn><mml:mo>,</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq37.gif"/></alternatives></inline-formula> and gene expression heritability <inline-formula id="IEq38"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}=\left(0.01,0.05,0.1\right)$$\end{document}</tex-math><mml:math id="M76"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>0.01</mml:mn><mml:mo>,</mml:mo><mml:mn>0.05</mml:mn><mml:mo>,</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq38.gif"/></alternatives></inline-formula> were considered in the simulation studies. Distribution of test <italic>R</italic><sup>2</sup> in 5000 simulations per method per scenario was presented using box-plot (<bold>A</bold>). The median was shown as a black bar. The lower and upper hinges corresponded to the 25th and 75th percentiles. Whiskers extended from the hinge to the value no further than 1.5 of the interquartile range. Data beyond the end of the whiskers were plotted individually. The GWAS sample size in the <italic>x</italic>-axis of panel <bold>B</bold> was chosen with respect to <inline-formula id="IEq39"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}$$\end{document}</tex-math><mml:math id="M78"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq39.gif"/></alternatives></inline-formula> values. The proportion of phenotype variance explained by gene expression (<inline-formula id="IEq40"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{p}^{2}$$\end{document}</tex-math><mml:math id="M80"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq40.gif"/></alternatives></inline-formula>) was set to be 0.025. TWAS was conducted using simulated GWAS <italic>Z</italic>-scores.</p></caption><graphic xlink:href="41467_2023_36862_Fig2_HTML" id="d32e2897"/></fig></p>
      <p id="Par15">To evaluate the type I error of the individual PRS methods along with OTTERS, we picked one simulated replicate per gene from the scenario with <inline-formula id="IEq41"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{e}^{2}=0.1$$\end{document}</tex-math><mml:math id="M82"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.1</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq41.gif"/></alternatives></inline-formula> and <inline-formula id="IEq42"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${p}_{{causal}}=0.001$$\end{document}</tex-math><mml:math id="M84"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq42.gif"/></alternatives></inline-formula>, simulated <inline-formula id="IEq43"><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$2\times {10}^{3}$$\end{document}</tex-math><mml:math id="M86"><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq43.gif"/></alternatives></inline-formula> phenotypes from <inline-formula id="IEq44"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$N({{{{\mathrm{0,1}}}}})$$\end{document}</tex-math><mml:math id="M88"><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">0, 1</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq44.gif"/></alternatives></inline-formula>, and permuted the eQTL weights for TWAS to perform a total of <inline-formula id="IEq45"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${10}^{6}$$\end{document}</tex-math><mml:math id="M90"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq45.gif"/></alternatives></inline-formula> null simulations. OTTERS was shown well calibrated in the tails of the distribution as shown by quantile-quantile (Q-Q) plots of TWAS <italic>p</italic> values in Supplementary Fig. <xref rid="MOESM1" ref-type="media">S1</xref>. We also observed that OTTERS had well-controlled type I error for stringent significance levels between <inline-formula id="IEq46"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${10}^{-4}$$\end{document}</tex-math><mml:math id="M92"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq46.gif"/></alternatives></inline-formula> and <inline-formula id="IEq47"><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${2.5\times 10}^{-6}$$\end{document}</tex-math><mml:math id="M94"><mml:msup><mml:mrow><mml:mn>2.5</mml:mn><mml:mo>×</mml:mo><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq47.gif"/></alternatives></inline-formula> (Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>), which are typically utilized in TWAS. For more modest significance thresholds (<inline-formula id="IEq48"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha={10}^{-2}$$\end{document}</tex-math><mml:math id="M96"><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq48.gif"/></alternatives></inline-formula>), we noted that OTTERS had a slightly inflated type I error rate. This modest inflation is consistent with the findings of the original ACAT-O work, which showed that the Cauchy-distribution-based approximation that ACAT-O employs might not be accurate for larger <italic>p</italic> values when the correlation among tests is strong<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. This suggests that modest OTTERS <italic>p</italic> values may be interpreted with caution.</p>
      <p id="Par16">We also compared the performance of our individual PRS training methods to those of FUSION, assuming individual-level reference data were available for the latter method to train GReX models. As shown in Fig. <xref rid="Fig2" ref-type="fig">2A</xref>, we interestingly observed that our training methods yielded similar or improved test <inline-formula id="IEq49"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M98"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq49.gif"/></alternatives></inline-formula> compared to FUSION in this situation, with SDPR and PRS-CS outperforming FUSION across all simulation settings. Comparing TWAS power, we found that OTTERS outperformed FUSION by a considerable margin in our simulations (Fig. <xref rid="Fig2" ref-type="fig">2B</xref>). These simulation results suggest that, while we developed OTTERS based on PRS training methods to handle summary-level reference data, OTTERS can still improve TWAS power when individual-level reference data are available. This is likely because OTTERS accounts for multiple possible models of genetic architectures of gene expression assumed by the different PRS training methods.</p>
    </sec>
    <sec id="Sec5">
      <title>GReX imputation accuracy in GTEx V8 blood samples</title>
      <p id="Par17">To evaluate the imputation accuracy of P+T (0.001), P+T (0.05), lassosum, SDPR, and PRS-CS methods in real data, we applied these training methods to summary-level eQTL reference data from the eQTLGen consortium<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> with <italic>n</italic> = 31,684 blood samples, to train GReX imputation models for 16,699 genes. For test data, we downloaded the transcriptomic data of 315 blood tissue samples that are in GTEx V8 but were not part of GTEx V6 (as GTEx V6 samples contributed to the reference eQTLGen consortium summary data). For these 315 samples, we compared imputed GReX to observed expression levels. We considered trained imputation models with test <inline-formula id="IEq50"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2} \, &gt; \, 0.01$$\end{document}</tex-math><mml:math id="M100"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mspace width="0.25em"/><mml:mo>&gt;</mml:mo><mml:mspace width="0.25em"/><mml:mn>0.01</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq50.gif"/></alternatives></inline-formula> as “valid” models, as suggested by previous TWAS methods<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>. We also compared the imputation accuracy of these five training models to those using FUSION based on a smaller individual-level training dataset (individual-level GTEx V6 reference dataset; see Methods). For such models, we compared the test <inline-formula id="IEq51"><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M102"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq51.gif"/></alternatives></inline-formula> for genes that had test <inline-formula id="IEq52"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2} &gt; 0.01$$\end{document}</tex-math><mml:math id="M104"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.01</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq52.gif"/></alternatives></inline-formula> by at least one training method.</p>
      <p id="Par18">We observed that PRS-CS obtained the most “valid” GReX imputation models with test <inline-formula id="IEq53"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M106"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq53.gif"/></alternatives></inline-formula> &gt; 0.01. Among 16,699 tested genes, PRS-CS obtained “valid” GReX imputation models for 10,337 genes, compared to 9816 genes by P+T (0.001) (5.0% less valid genes than PRS-CS), 9662 genes by P+T (0.05) (6.5% less), 8718 genes by lassosum (15.7% less), 9670 genes by SDPR (6.5% less), and 4704 genes by FUSION (54.5% less) (Table <xref rid="Tab1" ref-type="table">1</xref>). Among the “valid” GReX imputation models obtained by each method, the ones trained by PRS-CS have the highest median test <inline-formula id="IEq54"><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M108"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq54.gif"/></alternatives></inline-formula>. The P+T (0.001) method obtained the second most “valid” GReX imputation models with the second largest median test <inline-formula id="IEq55"><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M110"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq55.gif"/></alternatives></inline-formula>, as compared to P+T (0.05), lassosum, and SDPR (Table <xref rid="Tab1" ref-type="table">1</xref>). We note that the performance of PRS-CS method was not sensitive to the global-shrinkage parameter (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S2</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Test <italic>R</italic><sup>2</sup> in <italic>n</italic> = 315 whole blood tissue samples from GTEx V8</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>P+T (0.001)</th><th>P+T (0.05)</th><th>lassosum</th><th>SDPR</th><th>PRS-CS</th><th>FUSION<sup>b</sup></th></tr></thead><tbody><tr><td>No. of genes with <inline-formula id="IEq56"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M112"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq56.gif"/></alternatives></inline-formula> &gt; 0.01</td><td>9816</td><td>9662</td><td>8718</td><td>9670</td><td>10,337</td><td>4704</td></tr><tr><td>Median <inline-formula id="IEq57"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M114"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq57.gif"/></alternatives></inline-formula><sup>a</sup></td><td>0.0440</td><td>0.0430</td><td>0.0416</td><td>0.0418</td><td>0.0517</td><td>0.0367</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Median <inline-formula id="IEq58"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M116"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq58.gif"/></alternatives></inline-formula> among genes with test <inline-formula id="IEq59"><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2} &gt; 0.01$$\end{document}</tex-math><mml:math id="M118"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.01</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq59.gif"/></alternatives></inline-formula> per method.</p><p><sup>b</sup>FUSION was trained on GTEx V6 blood samples, while all other training methods were trained using eQTLGen summary statistics (<italic>n</italic> = 31,684) and reference LD from GTEx V8 samples.</p></table-wrap-foot></table-wrap></p>
      <p id="Par19">By comparing test <inline-formula id="IEq60"><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M120"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq60.gif"/></alternatives></inline-formula> per “valid” GReX imputation model by PRS-CS versus the other methods (Fig. <xref rid="Fig3" ref-type="fig">3</xref>), we observed that PRS-CS had the best overall performance for imputing GReX as it provided the most “valid” models with higher GReX imputation accuracy compared to P+T methods, lassosum, SDPR, and FUSION. Comparing the test <inline-formula id="IEq61"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M122"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq61.gif"/></alternatives></inline-formula> among the other four training methods, we observed that these two P+T methods obtained similar test <inline-formula id="IEq62"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M124"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq62.gif"/></alternatives></inline-formula> per “valid” model. Meanwhile, the test <inline-formula id="IEq63"><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M126"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq63.gif"/></alternatives></inline-formula> per valid model varied widely among the P+T methods, lassosum, and SDPR (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S3</xref>), suggesting that none of these four were optimal across all genes and their performance likely depended on the underlying unknown genetic architecture. These results are consistent with our simulation results.<fig id="Fig3"><label>Fig. 3</label><caption><title>Test <italic>R</italic><sup>2</sup> by PRS-CS versus P+T (0.001), P+T (0.05), lassosum, SDPR and FUSION.</title><p>Test <italic>R</italic><sup>2</sup> by PRS-CS versus P+T (0.001) (<bold>A</bold>), P+T (0.05) (<bold>B</bold>), lassosum (<bold>C</bold>), SDPR (<bold>D</bold>), and FUSION (<bold>E</bold>) with 315 GTEx V8 test samples, with different colors denoting whether test <italic>R</italic><sup>2</sup> &gt; 0.01 only by PRS-CS (red), only by the <italic>y</italic>-axis method (green), or both methods (blue). Genes with test <italic>R</italic><sup>2</sup> &gt; 0.01 by at least one method were included in the plot.</p></caption><graphic xlink:href="41467_2023_36862_Fig3_HTML" id="d32e3524"/></fig></p>
    </sec>
    <sec id="Sec6">
      <title>TWAS of cardiovascular disease</title>
      <p id="Par20">Using the eQTL weights trained by P+T (0.001), P+T (0.05), lassosum, SDPR, and PRS-CS methods with the eQTLGen<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> reference data and reference LD from GTEx V8 WGS samples<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, we applied our OTTERS framework to the summary-level GWAS data of Cardiovascular Disease from UKBB (<italic>n</italic> = 459,324, case fraction = 0.319)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> (see Methods). We performed TWAS of cardiovascular disease for 16,678 genes. First, for each gene, we obtained TWAS <italic>p</italic> values per individual training method (P+T (0.001), P+T (0.05), lassosum, SDPR, and PRS-CS). Second, we performed genomic control<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> for TWAS test statistics generated under each specific training model, by scaling all test statistics to ensure that the median test <italic>p</italic> value equals to 0.5. Last, we only considered genes with test GReX <inline-formula id="IEq64"><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2} &gt; 0.01$$\end{document}</tex-math><mml:math id="M128"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.01</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq64.gif"/></alternatives></inline-formula> by at least one PRS training method in additional GTEx V8 samples in the follow-up ACAT-O test. We combined the adjusted <italic>p</italic> values across all five training models using ACAT-O to obtain our OTTERS test statistics and <italic>p</italic> values. Genes with OTTERS <italic>p</italic> values &lt; <inline-formula id="IEq65"><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$2.998\times {10}^{-6}$$\end{document}</tex-math><mml:math id="M130"><mml:mn>2.998</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq65.gif"/></alternatives></inline-formula> (Bonferroni corrected significance level) were identified as significant TWAS genes for cardiovascular risk.</p>
      <p id="Par21">In total, we identified 40 significant TWAS genes by using OTTERS. To identify independently significant TWAS genes, we calculated the <inline-formula id="IEq66"><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M132"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq66.gif"/></alternatives></inline-formula> (squared Pearson correlation) between the GReX predicted by PRS-CS for each pair of genes. For a pair of genes with the predicted GReX <inline-formula id="IEq67"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2} &gt; 0.5$$\end{document}</tex-math><mml:math id="M134"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.5</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq67.gif"/></alternatives></inline-formula>, we only kept the gene with the smaller TWAS <italic>p</italic> value as the independently significant gene. OTTERS obtained 38 independently significant TWAS genes (Table <xref rid="Tab2" ref-type="table">2</xref> and Fig. <xref rid="Fig3" ref-type="fig">3B</xref>), compared to 17 independently significant genes by P+T (0.001), 11 by P+T (0.05), 10 by lassosum, 41 by SDPR, and 12 by PRS-CS. Among these 38 independent TWAS risk genes identified by OTTERS, gene <italic>RP11-378A13.1</italic> (OTTERS <italic>p</italic> value = <inline-formula id="IEq68"><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$9.78\times {10}^{-9}$$\end{document}</tex-math><mml:math id="M136"><mml:mn>9.78</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>9</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq68.gif"/></alternatives></inline-formula>) was not within 1 MB of any known GWAS risk loci with genomic-control corrected <italic>p</italic> value &lt; <inline-formula id="IEq69"><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$5\times {10}^{-8}$$\end{document}</tex-math><mml:math id="M138"><mml:mn>5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq69.gif"/></alternatives></inline-formula> in the UKBB summary-level GWAS data. This gene <italic>RP11-378A13.1</italic> was also identified to be a significant TWAS risk gene in blood tissue for systolic blood pressure, high cholesterol, and cardiovascular disease by FUSION<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Independent TWAS risk genes of cardiovascular disease identified by OTTERS</p></caption><table frame="hsides" rules="groups"><thead><tr><th>CHROM</th><th>ID</th><th>OTTERS</th><th>P+T (0.001)</th><th>P+T (0.05)</th><th>lassosum</th><th>SDPR</th><th>PRS-CS</th></tr></thead><tbody><tr><td>1</td><td>CLCN6<sup>a</sup></td><td><bold>5.75E–15</bold></td><td><bold>4.94E–09</bold></td><td><bold>5.40E–08</bold></td><td><bold>8.77E–09</bold></td><td><bold>1.19E–15</bold></td><td><bold>1.43E–09</bold></td></tr><tr><td>1</td><td>NPPA<sup>b</sup></td><td><bold>4.32E–08</bold></td><td><bold>1.55E–08</bold></td><td><bold>2.14E–07</bold></td><td><bold>–</bold></td><td><bold>–</bold></td><td>6.71E–06</td></tr><tr><td>1</td><td>PSRC1<sup>a</sup></td><td><bold>8.37E–20</bold></td><td><bold>5.68E–08</bold></td><td><bold>8.46E–07</bold></td><td><bold>6.26E–11</bold></td><td><bold>1.67E–20</bold></td><td><bold>1.41E–12</bold></td></tr><tr><td>2</td><td>RP11-378A13.1<sup>a</sup></td><td><bold>9.78E–09</bold></td><td>3.97E–02</td><td>4.98E–02</td><td>1.62E–05</td><td><bold>1.96E–09</bold></td><td>1.15E–04</td></tr><tr><td>4</td><td>LINC01093<sup>c</sup></td><td><bold>2.57E–09</bold></td><td>9.85E–02</td><td>5.31E–02</td><td><bold>5.13E–10</bold></td><td>1.08E–02</td><td>2.41E–02</td></tr><tr><td>5</td><td>CPEB4<sup>b</sup></td><td><bold>3.05E–14</bold></td><td>1.26E–02</td><td>2.05E–02</td><td>2.70E–05</td><td><bold>6.05E–15</bold></td><td><bold>1.60E–07</bold></td></tr><tr><td>6</td><td>SERPINB6<sup>c</sup></td><td><bold>1.47E–07</bold></td><td>2.12E–01</td><td>2.24E–01</td><td>7.56E–03</td><td><bold>2.95E–08</bold></td><td>7.53E–04</td></tr><tr><td>6</td><td>CARMIL1<sup>c</sup></td><td><bold>9.23E–09</bold></td><td>5.34E–03</td><td>3.41E–03</td><td>4.15E–03</td><td><bold>1.85E–09</bold></td><td>1.72E–03</td></tr><tr><td>6</td><td>ZSCAN12P1<sup>c</sup></td><td><bold>1.84E–08</bold></td><td>6.00E–01</td><td>5.75E–01</td><td>4.62E–01</td><td><bold>3.67E–09</bold></td><td>3.10E–01</td></tr><tr><td>6</td><td>HCG4P7<sup>c</sup></td><td><bold>8.93E–50</bold></td><td>3.70E–01</td><td>3.69E–01</td><td>2.30E–01</td><td><bold>1.79E–50</bold></td><td>7.26E–01</td></tr><tr><td>6</td><td>HCG4P3<sup>c</sup></td><td><bold>5.33E–20</bold></td><td>4.20E–01</td><td>4.05E–01</td><td>5.03E–04</td><td><bold>1.07E–20</bold></td><td>2.42E–03</td></tr><tr><td>6</td><td>HLA-S<sup>c</sup></td><td><bold>4.57E–07</bold></td><td>7.13E–01</td><td>7.31E–01</td><td>3.02E–01</td><td><bold>9.14E–08</bold></td><td>2.33E–01</td></tr><tr><td>7</td><td>PSPHP1<sup>c</sup></td><td><bold>1.21E–09</bold></td><td>2.17E–01</td><td>2.26E–01</td><td>9.65E–03</td><td><bold>2.43E–10</bold></td><td>1.10E–01</td></tr><tr><td>8</td><td>LPL<sup>c</sup></td><td><bold>5.73E–07</bold></td><td>1.78E–03</td><td>3.26E–03</td><td>4.44E–02</td><td><bold>1.15E–07</bold></td><td>1.05E–04</td></tr><tr><td>8</td><td>PTP4A3<sup>c</sup></td><td><bold>1.28E–06</bold></td><td>8.13E–02</td><td>8.33E–02</td><td>6.23E–05</td><td><bold>2.58E–07</bold></td><td>1.67E–03</td></tr><tr><td>10</td><td>CAMK1D<sup>a</sup></td><td><bold>2.51E–09</bold></td><td>3.83E–02</td><td>4.97E–02</td><td>1.23E–03</td><td><bold>5.03E–10</bold></td><td>4.97E–05</td></tr><tr><td>10</td><td>NT5C2<sup>b</sup></td><td><bold>1.21E–07</bold></td><td><bold>1.69E–06</bold></td><td><bold>2.92E–06</bold></td><td>1.64E–05</td><td><bold>3.15E–07</bold></td><td><bold>2.69E–08</bold></td></tr><tr><td>11</td><td>TNNT3<sup>b</sup></td><td><bold>1.67E–10</bold></td><td><bold>1.09E–06</bold></td><td>3.33E–06</td><td><bold>2.03E–09</bold></td><td><bold>3.40E–11</bold></td><td><bold>4.01E–07</bold></td></tr><tr><td>11</td><td>C11orf49<sup>b</sup></td><td><bold>2.28E–06</bold></td><td><bold>8.55E–07</bold></td><td><bold>1.78E–06</bold></td><td>5.44E–05</td><td><bold>–</bold></td><td>2.93E–04</td></tr><tr><td>11</td><td>SIDT2<sup>a</sup></td><td><bold>7.26E–09</bold></td><td>6.14E–05</td><td>1.33E–04</td><td>3.66E–05</td><td><bold>1.46E–09</bold></td><td><bold>3.81E–07</bold></td></tr><tr><td>15</td><td>CSK<sup>b</sup></td><td><bold>2.30E–09</bold></td><td><bold>1.70E–07</bold></td><td><bold>2.15E–06</bold></td><td><bold>7.41E–10</bold></td><td><bold>2.80E–09</bold></td><td><bold>2.17E–09</bold></td></tr><tr><td>15</td><td>FES<sup>b</sup></td><td><bold>2.87E–32</bold></td><td><bold>4.78E–08</bold></td><td><bold>1.23E–06</bold></td><td><bold>9.13E–24</bold></td><td><bold>5.75E–33</bold></td><td><bold>1.94E–15</bold></td></tr><tr><td>15</td><td>SLCO3A1<sup>c</sup></td><td><bold>3.78E–08</bold></td><td>1.85E–02</td><td>3.15E–02</td><td>4.65E–05</td><td><bold>7.57E–09</bold></td><td>1.14E–03</td></tr><tr><td>16</td><td>MBTPS1<sup>b</sup></td><td><bold>5.80E–08</bold></td><td>2.62E–01</td><td>3.05E–01</td><td>9.15E–04</td><td><bold>1.16E–08</bold></td><td>2.34E–03</td></tr><tr><td>16</td><td>MTHFSD<sup>a</sup></td><td><bold>4.65E–07</bold></td><td>5.16E–02</td><td>5.94E–02</td><td>1.65E–02</td><td><bold>9.30E–08</bold></td><td>3.20E–03</td></tr><tr><td>17</td><td>ACE<sup>b</sup></td><td><bold>9.42E–07</bold></td><td>4.93E–06</td><td>1.03E–05</td><td>4.23E–06</td><td><bold>9.66E–07</bold></td><td><bold>2.68E–07</bold></td></tr><tr><td>18</td><td>RALBP1<sup>c</sup></td><td><bold>1.40E–06</bold></td><td>1.48E–01</td><td>1.54E–01</td><td>2.12E–04</td><td><bold>2.81E–07</bold></td><td>5.55E–03</td></tr><tr><td>19</td><td>MRI1<sup>b</sup></td><td><bold>8.38E–09</bold></td><td>8.34E–03</td><td>1.60E–02</td><td>7.79E–03</td><td><bold>1.68E–09</bold></td><td>2.65E–03</td></tr><tr><td>19</td><td>HAUS8<sup>b</sup></td><td><bold>1.60E–07</bold></td><td><bold>4.41E–08</bold></td><td><bold>1.38E–07</bold></td><td><bold>1.67E–06</bold></td><td><bold>1.42E–06</bold></td><td>3.29E–05</td></tr><tr><td>19</td><td>SULT2B1<sup>c</sup></td><td><bold>2.32E–06</bold></td><td><bold>7.73E–07</bold></td><td><bold>–</bold></td><td>–</td><td>2.97E–02</td><td>1.10E–02</td></tr><tr><td>19</td><td>NTN5<sup>a</sup></td><td><bold>9.03E–10</bold></td><td><bold>2.75E–08</bold></td><td><bold>1.16E–07</bold></td><td>6.23E–06</td><td><bold>1.85E–10</bold></td><td><bold>9.73E–09</bold></td></tr><tr><td>19</td><td>RPL28<sup>b</sup></td><td><bold>3.76E–07</bold></td><td>7.33E–02</td><td>1.16E–01</td><td>6.64E–03</td><td><bold>7.52E–08</bold></td><td>4.23E–03</td></tr><tr><td>20</td><td>CTSZ<sup>b</sup></td><td><bold>3.32E–09</bold></td><td>2.57E–02</td><td>1.99E–02</td><td><bold>3.40E–09</bold></td><td><bold>8.25E–10</bold></td><td>1.04E–01</td></tr><tr><td>20</td><td>EDN3<sup>c</sup></td><td><bold>1.29E–07</bold></td><td><bold>3.61E–08</bold></td><td><bold>9.15E–08</bold></td><td>8.60E–06</td><td>5.90E–03</td><td>1.58E–02</td></tr><tr><td>20</td><td>ZBTB46<sup>c</sup></td><td><bold>1.07E–06</bold></td><td><bold>2.83E–07</bold></td><td>8.35E–06</td><td>–</td><td>1.81E–03</td><td>1.27E–05</td></tr><tr><td>20</td><td>OPRL1<sup>a</sup></td><td><bold>5.84E–07</bold></td><td><bold>3.44E–07</bold></td><td><bold>2.69E–06</bold></td><td>1.85E–03</td><td>5.51E–05</td><td><bold>1.90E–07</bold></td></tr><tr><td>21</td><td>FAM3B<sup>c</sup></td><td><bold>1.08E–10</bold></td><td>2.28E–02</td><td>2.58E–02</td><td>8.07E–06</td><td><bold>2.17E–11</bold></td><td>1.04E–05</td></tr><tr><td>21</td><td>MX1<sup>c</sup></td><td><bold>6.04E–22</bold></td><td>4.36E–01</td><td>3.83E–01</td><td><bold>3.16E–07</bold></td><td><bold>1.21E–22</bold></td><td>1.24E–03</td></tr></tbody></table><table-wrap-foot><p>Reference eQTL summary data from eQTLGen consortium and GWAS summary data from UKBB were used. The corresponding TWAS <italic>p</italic> values by 5 individual PRS methods and OTTERS are shown in the table with significant <italic>p</italic> values &lt; <inline-formula id="IEq70"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$2.998\times {10}^{-6}$$\end{document}</tex-math><mml:math id="M140"><mml:mn>2.998</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq70.gif"/></alternatives></inline-formula> (Bonferroni corrected significance level) in bold, and those for genes with test GReX <inline-formula id="IEq71"><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M142"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq71.gif"/></alternatives></inline-formula> ≤ 0.01 are shown as a dash. <italic>p</italic> values were the genomic-control corrected <italic>p</italic> values from the <italic>Z</italic>-score test from TWAS (two-sided).</p><p><sup>a</sup>Risk gene of UKBB cardiovascular disease in TWAS-hub identified using GTEx whole blood tissue.</p><p><sup>b</sup>Risk genes of UKBB cardiovascular disease in TWAS-hub identified using other GTEx tissue types.</p><p><sup>c</sup>Risk gene of UKBB cardiovascular disease not in TWAS-hub.</p></table-wrap-foot></table-wrap></p>
      <p id="Par22">We compared our OTTERS results with the TWAS results shown on TWAS hub (see Data availability) obtained by FUSION using the same UKBB GWAS summary data of cardiovascular disease but using a smaller individual-level reference expression dataset from GTEx V6 (whole blood tissue, <italic>n</italic> = 338). Of the 38 independent genes that OTTERS identified from TWAS with eQTLGen reference data of whole blood, FUSION only identified 8 of these genes (<italic>CLCN6, PSRC1, RP11-378A13.1, CAMK1D, SIDT2, MTHFSD, NTN5, OPRL1</italic>) when using the GTEx V6 reference data of the same tissue. FUSION did identify 13 additional OTTERS genes (<italic>NPPA, CPEB4, NT5C2, TNNT3, C11orf49, CSK, FES, MBTPS1, ACE, MRI1, HAUS8, RPL28, CTSZ</italic>), when considering all available tissue types in GTEx V6 reference data. These genes were identified by FUSION when considering the GTEx V6 reference data of artery, thyroid, adipose visceral, nerve tibial tissues, etc. For example, the most significant gene <italic>FES</italic> (OTTERS <italic>p</italic> value = <inline-formula id="IEq72"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$2.87\times {10}^{-32}$$\end{document}</tex-math><mml:math id="M144"><mml:mn>2.87</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>32</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq72.gif"/></alternatives></inline-formula>) was identified by FUSION using GTEx reference data of artery tibial, thyroid, and adipose visceral omentum tissues, and was also identified as a TWAS risk gene for high blood pressure, which is strongly related to cardiovascular disease<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>.</p>
      <p id="Par23">Our OTTERS method also identified 17 genes (<italic>LINC01093</italic>, <italic>SERPINB6</italic>, <italic>CARMIL1</italic>, <italic>ZSCAN12P1</italic>, <italic>HCG4P7</italic>, <italic>HCG4P3</italic>, <italic>HLA-S</italic>, <italic>PSPHP1</italic>, <italic>LPL</italic>, <italic>PTP4A3</italic>, <italic>SLCO3A1</italic>, <italic>RALBP1</italic>, <italic>SULT2B1</italic>, <italic>EDN3</italic>, <italic>ZBTB46</italic>, <italic>FAM3B</italic>, <italic>MX1</italic>) that were not detected by FUSION using GTEx V6 data, where <italic>EDN3</italic> (Endothelin 3, a member of the endothelin family) was shown to be active in the cardiovascular system and play an important role in the maintenance of blood pressure or generation of hypertension<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>.</p>
      <p id="Par24">By comparing OTTERS results with the ones obtained by individual methods (Table <xref rid="Tab2" ref-type="table">2</xref>, Fig. <xref rid="Fig4" ref-type="fig">4</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">S4</xref>), we found that all individual methods contributed to the OTTERS results. For example, the gene <italic>LINC01093</italic> was only identified by lassosum, while genes <italic>CPEB4, SIDT2</italic>, and <italic>ACE</italic> were only detected by PRS-CS and SDPR and the gene <italic>EDN3</italic> was only identified by the P+T methods. To better understand the differences among individual methods, we plotted the eQTL weights estimated by P+T (0.001), P+T (0.05), lassosum, SDPR, and PRS-CS for three example genes that were only detected by one or two individual methods (Supplementary Figs. <xref rid="MOESM1" ref-type="media">S5</xref>–<xref rid="MOESM1" ref-type="media">S7</xref>). For these genes, we plotted the eQTL weights produced by each method with such weights color coded with respect to <inline-formula id="IEq73"><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$-{{{\log }}}_{10}$$\end{document}</tex-math><mml:math id="M146"><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>log</mml:mi></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq73.gif"/></alternatives></inline-formula>(GWAS <italic>p</italic> values) from the UKBB GWAS summary statistics and shape coded with respect to the direction of UKBB GWAS <italic>Z</italic>-score statistics. Generally, significant TWAS <italic>p</italic> values would be obtained by methods that obtained eQTL weights with relatively large magnitudes for SNPs with relatively more significant GWAS <italic>p</italic> values.<fig id="Fig4"><label>Fig. 4</label><caption><title>Manhattan plot of TWAS results by OTTERS.</title><p>Manhattan plot of TWAS results by OTTERS using GWAS summary-level statistics of cardiovascular disease and imputation models fitted based on eQTLGen summary statistics. The <italic>x</italic>-axis represented the genomic position, and the <italic>y</italic>-axis represented –log<sub>10</sub>(<italic>p</italic> values). <italic>p</italic> values were the genomic-control corrected <italic>p</italic> values from the <italic>Z</italic>-score test from TWAS (two-sided). Independently significant TWAS risk genes were labeled.</p></caption><graphic xlink:href="41467_2023_36862_Fig4_HTML" id="d32e5166"/></fig></p>
      <p id="Par25">In Supplementary Fig. <xref rid="MOESM1" ref-type="media">S5</xref>, we showed the eQTL weights for gene <italic>SIDT2</italic>, which was a significant risk gene identified by both PRS-CS and SDPR, and had <italic>p</italic> values &lt; <inline-formula id="IEq74"><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${10}^{-4}$$\end{document}</tex-math><mml:math id="M148"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq74.gif"/></alternatives></inline-formula> by other methods. Compared to lassosum, SDPR had more significant GWAS SNPs colocalized with eQTLs having relatively large weights in the test region, and PRS-CS had more non-significant GWAS SNPs colocalized with eQTLs having zero weights. Compared to the P+T methods, SDPR and PRS-CS based on a multivariate regression model modeled LD among all test SNPs, and thus estimated eQTL weights leading to significant TWAS findings. In Supplementary Fig. <xref rid="MOESM1" ref-type="media">S6</xref>, we provided the results of gene <italic>EDN3</italic>, which was only identified by P+T methods (<italic>p</italic> values <inline-formula id="IEq75"><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\le 9.15\times {10}^{-8}$$\end{document}</tex-math><mml:math id="M150"><mml:mo>≤</mml:mo><mml:mn>9.15</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq75.gif"/></alternatives></inline-formula>). Compared to P+T methods, SDPR (<italic>p</italic> value = <inline-formula id="IEq76"><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$5.9\times {10}^{-3}$$\end{document}</tex-math><mml:math id="M152"><mml:mn>5.9</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq76.gif"/></alternatives></inline-formula>) and PRS-CS (<italic>p</italic> value = <inline-formula id="IEq77"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$0.0158$$\end{document}</tex-math><mml:math id="M154"><mml:mn>0.0158</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq77.gif"/></alternatives></inline-formula>) had fewer significant GWAS SNPs colocalized with eQTLs that had relatively large weights in the test region, while lassosum (<italic>p</italic> value = <inline-formula id="IEq78"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$8.6\times {10}^{-6}$$\end{document}</tex-math><mml:math id="M156"><mml:mn>8.6</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq78.gif"/></alternatives></inline-formula>) assigned relatively large weights to more non-significant GWAS SNPs. In Supplementary Fig. <xref rid="MOESM1" ref-type="media">S7</xref>, we provided results for gene <italic>LINC01093</italic>, which was only identified by lassosum. For this gene, SDPR and PRS-CS estimated near-zero weights for most test SNPs with significant GWAS <italic>p</italic> values in the test region. Most significant GWAS SNPs did not have eQTL test <italic>p</italic> values &lt; 0.001 or 0.05, and were thus filtered out by P+T methods. lassosum was the only method that produced relatively large eQTL weights that colocalized with GWAS-significant SNPs.</p>
      <p id="Par26">These results were consistent with our simulation study results, demonstrating that the performance of different individual methods depended on the underlying genetic architecture. We do note that there were a handful of genes identified by an individual method that were not significant using OTTERS (Supplementary Table <xref rid="MOESM1" ref-type="media">S2</xref>). Nonetheless, the omnibus test borrows strength across all individual methods, thus generally achieving higher TWAS power and identifying the group of most robust TWAS risk genes.</p>
      <p id="Par27">By examining the Q-Q plots of TWAS <italic>p</italic> values, we observed moderate inflation for all methods (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S8</xref>). Such inflation in TWAS results is not uncommon<sup><xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR50">50</xref></sup>, which could be due to similar inflation in the GWAS summary data and not distinguishing the pleiotropy and mediation effects for considered gene expression and phenotype of interest<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S9</xref>). We also observed a notable inflation in the GWAS <italic>p</italic> values of cardiovascular disease from UKBB (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S9</xref>), as we estimated the LD score regression<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> intercept to be 1.1 from the GWAS summary data.</p>
      <p id="Par28">We did not consider directly comparing to FUSION in our above TWAS analyses of cardiovascular disease since we used the summary-level reference data eQTLGen. However, to assess the performance of OTTERS and FUSION in a real study where individual-level reference data are available, we performed an additional TWAS analysis of cardiovascular disease in the UK Biobank using the GTEx V8 data of 574 whole blood samples as the reference data. We trained OTTERS Stage I using cis-eQTL summary statistics obtained from these 574 GTEx V8 whole blood samples and reference LD from GTEx V8 WGS samples, and trained FUSION models using individual-level genotype data and gene expression data of the same 574 whole blood samples.</p>
      <p id="Par29">We tested TWAS association for 19,653 genes and identified genes with TWAS <italic>p</italic> values &lt; <inline-formula id="IEq79"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$2.53\times {10}^{-6}$$\end{document}</tex-math><mml:math id="M158"><mml:mn>2.53</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq79.gif"/></alternatives></inline-formula> (Bonferroni corrected significance level) as significant TWAS genes. Training <inline-formula id="IEq80"><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2} &gt; 0.01$$\end{document}</tex-math><mml:math id="M160"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.01</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq80.gif"/></alternatives></inline-formula> was used to select “valid” GReX imputation models for TWAS (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S10</xref>). To identify independently significant TWAS genes, we calculated the training <inline-formula id="IEq81"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M162"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq81.gif"/></alternatives></inline-formula> between the GReX predicted by lassosum for of each pair of genes, since lassosum had the best training <inline-formula id="IEq82"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M164"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq82.gif"/></alternatives></inline-formula> (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S10</xref>). For a pair of genes with the predicted GReX <inline-formula id="IEq83"><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M166"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq83.gif"/></alternatives></inline-formula> &gt; 0.5, we only kept the gene with the smaller TWAS <italic>p</italic> value as the independently significant gene. As a result, OTTERS obtained 34 independently significant TWAS genes, while FUSION identified 21 independently significant TWAS genes (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S11</xref>). A total of 14 genes were identified by both FUSION and OTTERS (Supplementary Table <xref rid="MOESM1" ref-type="media">S3</xref>).</p>
      <p id="Par30">These results demonstrate the advantages of OTTERS for using multiple PRS training methods to account for the unknown genetic architecture of gene expression, which is consistent in our simulation results. These results also showed the advantage of using eQTL summary data with a larger training sample size, as more independently significant TWAS genes were identified by using the eQTLGen summary reference data (38 vs. 34), even with a more stringent rule (test instead of training <inline-formula id="IEq84"><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2} &gt; 0.01$$\end{document}</tex-math><mml:math id="M168"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.01</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq84.gif"/></alternatives></inline-formula>) applied to select test genes with “valid” GReX imputation models.</p>
    </sec>
    <sec id="Sec7">
      <title>Computational time</title>
      <p id="Par31">The computational time per gene of different PRS methods depends on the number of test variants considered for the target gene. Thus, we calculated the computational time and memory usage for four groups of genes whose test variants were &lt;2000, between 2000 and 3000, between 3000 and 4000, and &gt;4000, respectively. Among all tested genes in our real studies, the median number of test variants per gene is 3152, and the proportion of genes in each group is 10.3%, 33.4%, 34.5%, and 21.8%, respectively. For each group, we randomly selected ten genes on Chromosome 4 to evaluate the average computational time and memory usage per gene. We benchmarked the computational time and memory usage of each method on one Intel(R) Xeon(R) processor (2.10 GHz). The evaluation was based on 1000 MCMC iterations for SDPR and PRS-CS (default) without parallel computation (Supplementary Table <xref rid="MOESM1" ref-type="media">S4</xref>). We showed that P+T and lassosum were computationally more efficient than SDPR and PRS-CS, whose speeds were impeded by the need of MCMC iterations. Between the two Bayesian methods, SDPR implemented in C++ uses significantly less time and memory than PRS-CS implemented in Python.</p>
    </sec>
  </sec>
  <sec id="Sec8" sec-type="discussion">
    <title>Discussion</title>
    <p id="Par32">Our OTTERS framework represents an omnibus TWAS tool that can leverage summary-level expression and genotype results from a reference sample, thereby robustly expanding the use of TWAS into more settings. To this end, we adapted and evaluated five different PRS methods assuming different underlying genetic models, including the relatively simple method P+T<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> with two different <italic>p</italic> value thresholds (0.001 and 0.05), the frequentist method lassosum<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, as well as the Bayesian methods PRS-CS<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> and SDPR<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> within our omnibus test for optimal inference. We note that additional PRS methods such as MegaPRS<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> or PUMAS<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> could also be implemented as additional OTTERS Stage I training methods. Higher TWAS power might be obtained by adding more PRS methods in OTTERS Stage I, with additional computation cost. We also note that the existing SMR-HEIDI<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> method, which uses summary-level data from GWAS and eQTL studies to test for possible causal genetic effects of a trait of interest that were mediated through gene expression, could also be used as an alternative method besides TWAS. However, the SMR method generally restricts eQTL for consideration, excluding those where the eQTL <italic>p</italic> values larger than a certain threshold, e.g., 0.05.</p>
    <p id="Par33">In simulation studies, we demonstrated that the performance of each of these five PRS methods depended substantially on the underlying genetic architecture for gene expression, with P+T methods generally performing better for sparse architecture, whereas the Bayesian methods performing better for denser architecture. Consequently, since the genetic architecture of gene expression is unknown apriori, we believe this justifies the use of the omnibus TWAS test implemented in OTTERS for practical use, as this test had near-optimal performance across all simulation scenarios considered. While we developed our methods with summary-level reference data in mind, we note that our prediction methods and OTTERS perform well (in terms of imputation accuracy and power) relative to existing TWAS methods like FUSION when individual-level reference data are available.</p>
    <p id="Par34">In our real data application using UKBB GWAS summary-level data, we compared OTTERS TWAS results using reference eQTL summary data from eQTLGen consortium to FUSION TWAS results using a substantially smaller individual-level reference dataset from GTEx V6. OTTERS identified 13 significant TWAS risk genes that were missed by FUSION using individual-level GTEx V6 reference data of blood tissue, suggesting that the use of larger reference datasets like eQTLGen in TWAS can provide additional findings. Interestingly, the genes missed by FUSION were instead detected using individual-level GTEx reference data of other tissue types that are more directly related to cardiovascular disease. By comparing OTTERS to FUSION when the same individual-level GTEx V8 reference data of whole blood samples were used, we still observed that OTTERS identified more risk genes than FUSION, which we believe is due to the former method accounting for the unknown genetic architecture of gene expression by using multiple regression methods to train GReX imputation models. These applied results were consistent with our simulation results.</p>
    <p id="Par35">Among all individual methods, P+T is the most computationally efficient method. The Bayesian methods SDPR and PRS-CS require more computation time than the frequentist method lassosum as the former set of methods require a large number of MCMC iterations for model fit. By comparing the performance of these five methods in terms of the imputation accuracy and TWAS power in simulations and real applications, we conclude that none of these methods was optimal across different genetic architectures. We found that all methods provided distinct and considerable contributions to the final OTTERS TWAS results. These results demonstrate the benefits of OTTERS in practice, since OTTERS can combine the strength of these individual methods to achieve optimal performance.</p>
    <p id="Par36">To enable the use of OTTERS by the public, we provide an integrated tool (see Code Availability) to (1) Train GReX imputation models (i.e., estimate eQTL weights in Stage I) using eQTL summary data by P+T, lassosum, SDPR, and PRS-CS; (2) Conduct TWAS (i.e., testing gene-trait association in Stage II) using both individual-level and summary-level GWAS data with the estimated eQTL weights; and (3) Apply ACAT-O to aggregate the TWAS <italic>p</italic> values from individual training methods. Since the existing tools for P+T, lassosum, SDPR, and PRS-CS were originally developed for PRS calculations, we adapted and optimized them for training GReX imputation models in our OTTERS tool. For example, we integrate TABIX<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> and PLINK<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> tools in OTTERS to extract input data per target gene more efficiently. We also enable parallel computation in OTTERS for training GReX imputation models and testing gene-trait association of multiple genes.</p>
    <p id="Par37">The OTTERS framework does have its limitations. First, training GReX imputation models by all individual methods on average cost ~20 min for all five training models per gene, which might be computationally challenging for studying eQTL summary data of multiple tissue types and for ~20K genome-wide genes. Users might consider prioritizing P+T (0.001), lassosum, and SDPR training methods, as these three provide complementary results in our studies. Second, the currently available eQTL summary statistics are mainly derived from individuals of European descent. Our OTTERS trained GReX imputations model based on these eQTL summary statistics, and the resulting imputed GReX could consequently have attenuated cross-population predictive performance<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. This might limit the transferability of our TWAS results across populations. Third, our OTTERS cannot provide the direction of the identified gene-phenotype associations, which should be referred to as the sign of the TWAS <italic>Z</italic>-score statistic per training method. Last, even though the method applies to integrate both cis- and trans- eQTL with GWAS data, the computation time and availability of summary-level trans-eQTL reference data are still the main obstacles. Our current OTTERS tool only considers cis-eQTL effects. Extension of OTTERS to enable cross-population TWAS and incorporation of trans-eQTL effects is part of our ongoing research but is out of the scope of this work.</p>
    <p id="Par38">Our OTTERS framework using large-scale eQTL summary data has the potential to identify more significant TWAS risk genes than standard TWAS tools that use smaller individual-level reference transcriptomic data and use only a single regression method for training GReX imputation models. This tool provides the opportunity to leverage not only available public eQTL summary data of various tissues for conducting TWAS of complex traits and diseases, but also the emerging summary-level data of other types of molecular QTL such as splicing QTLs, methylation QTLs, metabolomics QTLs, and protein QTLs. For example, OTTERS could be applied to perform proteome-wide association studies using summary-level reference data of genetic-protein relationships such as those reported by the SCALLOP consortium<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>, and epigenome-wide association studies using summary-level reference data of methylation-phenotype relationships reported by Genetics of DNA Methylation Consortium (GoDMC) (see Data availability). OTTERS would be most useful for broad researchers who only have access to summary-level QTL reference data and summary-level GWAS data. The feasibility of integrating summary-level molecular QTL data and GWAS data makes our OTTERS tool valuable for wide application in current multi-omics studies of complex traits and diseases.</p>
  </sec>
  <sec id="Sec9">
    <title>Methods</title>
    <sec id="Sec10">
      <title>Traditional two-stage TWAS analysis</title>
      <p id="Par39">Stage I of TWAS estimates a GReX imputation model using individual-level expression and genotype data available from a reference dataset. Consider the following GReX imputation model from <inline-formula id="IEq85"><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n$$\end{document}</tex-math><mml:math id="M170"><mml:mi>n</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq85.gif"/></alternatives></inline-formula> individuals and <inline-formula id="IEq86"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$m$$\end{document}</tex-math><mml:math id="M172"><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq86.gif"/></alternatives></inline-formula> SNPs (multivariable regression model assuming linear additive genetic effects) within the reference dataset:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}={{{{{{\bf{X}}}}}}}_{g}{{{{{\bf{w}}}}}}+{{{{{{\boldsymbol{\epsilon }}}}}}}_{g},{{{{{{\boldsymbol{\epsilon }}}}}}}_{g}\sim N\left(0,{\sigma }_{\epsilon }^{2}{{{{{\bf{I}}}}}}\right).$$\end{document}</tex-math><mml:math id="M174"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">w</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mi mathvariant="bold">I</mml:mi></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math><graphic xlink:href="41467_2023_36862_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par40">Here, <inline-formula id="IEq87"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M176"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq87.gif"/></alternatives></inline-formula> is a vector representing gene expression levels of gene <inline-formula id="IEq88"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$g$$\end{document}</tex-math><mml:math id="M178"><mml:mi>g</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq88.gif"/></alternatives></inline-formula>, <inline-formula id="IEq89"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M180"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq89.gif"/></alternatives></inline-formula> is an <inline-formula id="IEq90"><alternatives><tex-math id="M181">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n\times m$$\end{document}</tex-math><mml:math id="M182"><mml:mi>n</mml:mi><mml:mo>×</mml:mo><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq90.gif"/></alternatives></inline-formula> matrix of genotype data of SNP predictors proximal or within gene <inline-formula id="IEq91"><alternatives><tex-math id="M183">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$g$$\end{document}</tex-math><mml:math id="M184"><mml:mi>g</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq91.gif"/></alternatives></inline-formula>, <inline-formula id="IEq92"><alternatives><tex-math id="M185">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{w}}}}}}$$\end{document}</tex-math><mml:math id="M186"><mml:mi mathvariant="bold">w</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq92.gif"/></alternatives></inline-formula> is a vector of genetic effect sizes (referred to as a broad sense of eQTL effect sizes), and <inline-formula id="IEq93"><alternatives><tex-math id="M187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\boldsymbol{\epsilon }}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M188"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq93.gif"/></alternatives></inline-formula> is the error term. Here, we consider only cis-SNPs within 1 MB of the flanking 5’ and 3’ ends as genotype predictors that are coded within <inline-formula id="IEq94"><alternatives><tex-math id="M189">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M190"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq94.gif"/></alternatives></inline-formula><sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. Once we configure the model in Eq. (<xref rid="Equ1" ref-type="disp-formula">1</xref>), we can employ methods like PrediXcan, FUSION, and TIGAR to fit the model and obtain estimates of eQTL effect sizes (<inline-formula id="IEq95"><alternatives><tex-math id="M191">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M192"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq95.gif"/></alternatives></inline-formula>).</p>
      <p id="Par41">Stage II of TWAS uses the eQTL effect sizes (<inline-formula id="IEq96"><alternatives><tex-math id="M193">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M194"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq96.gif"/></alternatives></inline-formula>) from Stage I to impute gene expression (GReX) in an independent GWAS and then test for association between GReX and phenotype. Given individual-level GWAS data with genotype data <inline-formula id="IEq97"><alternatives><tex-math id="M195">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{{{{{{\rm{new}}}}}}}$$\end{document}</tex-math><mml:math id="M196"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">new</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq97.gif"/></alternatives></inline-formula> and eQTL effect sizes (<inline-formula id="IEq98"><alternatives><tex-math id="M197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M198"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq98.gif"/></alternatives></inline-formula>) from Stage I, the GReX for <inline-formula id="IEq99"><alternatives><tex-math id="M199">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{{{{{{\rm{new}}}}}}}$$\end{document}</tex-math><mml:math id="M200"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">new</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq99.gif"/></alternatives></inline-formula> can be imputed by <inline-formula id="IEq100"><alternatives><tex-math id="M201">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{{{{{\bf{GReX}}}}}}}={{{{{{\bf{X}}}}}}}_{{{{{{\rm{new}}}}}}}\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M202"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">GReX</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">new</mml:mi></mml:mrow></mml:msub><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq100.gif"/></alternatives></inline-formula>. The follow-up TWAS would test the association between <inline-formula id="IEq101"><alternatives><tex-math id="M203">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{{{{{\bf{GReX}}}}}}}$$\end{document}</tex-math><mml:math id="M204"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">GReX</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq101.gif"/></alternatives></inline-formula> and phenotype <inline-formula id="IEq102"><alternatives><tex-math id="M205">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{y}}}}}}$$\end{document}</tex-math><mml:math id="M206"><mml:mi mathvariant="bold">y</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq102.gif"/></alternatives></inline-formula> based on a generalized linear regression model, which is equivalent to a gene-based association test taking <inline-formula id="IEq103"><alternatives><tex-math id="M207">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M208"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq103.gif"/></alternatives></inline-formula> as test SNP weights. When individual-level GWAS data are not available, one can apply FUSION and S-PrediXcan test statistics to summary-level GWAS data as follows:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M209">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${Z}_{g,{FUSION}}=\frac{{\sum }_{j=1}^{J}({\hat{w}}_{j}{Z}_{j})}{\sqrt{{\hat{{{{{{\bf{w}}}}}}}}^{\prime}{{{{{\bf{V}}}}}}\hat{{{{{{\bf{w}}}}}}}}},\, {Z}_{g,\, S-{PrediXcan}}=\frac{{\sum }_{j=1}^{J}({\hat{w}}_{j}{{\hat{\sigma }}_{j}Z}_{j})}{\sqrt{{\hat{{{{{{\bf{w}}}}}}}}^{\prime}{{{{{\bf{V}}}}}}\hat{{{{{{\bf{w}}}}}}}}}$$\end{document}</tex-math><mml:math id="M210"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mi>F</mml:mi><mml:mi>U</mml:mi><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mi>O</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mo mathsize="big">∑</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>J</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msqrt><mml:mrow><mml:msup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msup><mml:mi mathvariant="bold">V</mml:mi><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mi>S</mml:mi><mml:mo>−</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>X</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mo mathsize="big">∑</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>J</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msqrt><mml:mrow><mml:msup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msup><mml:mi mathvariant="bold">V</mml:mi><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41467_2023_36862_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq104"><alternatives><tex-math id="M211">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${Z}_{j}$$\end{document}</tex-math><mml:math id="M212"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq104.gif"/></alternatives></inline-formula> is the single variant <italic>Z</italic>-score test statistic in GWAS for the <italic>j</italic>th SNP, <inline-formula id="IEq105"><alternatives><tex-math id="M213">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$j=1,\ldots,\,J$$\end{document}</tex-math><mml:math id="M214"><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mi>J</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq105.gif"/></alternatives></inline-formula>, for all test SNPs that have both eQTL weights with respect to the test gene <inline-formula id="IEq106"><alternatives><tex-math id="M215">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$g$$\end{document}</tex-math><mml:math id="M216"><mml:mi>g</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq106.gif"/></alternatives></inline-formula> and GWAS <italic>Z</italic>-scores; <inline-formula id="IEq107"><alternatives><tex-math id="M217">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\hat{\sigma }}_{j}$$\end{document}</tex-math><mml:math id="M218"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq107.gif"/></alternatives></inline-formula> is the genotype standard deviation of the <italic>j</italic>th SNP; and <inline-formula id="IEq108"><alternatives><tex-math id="M219">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{V}}}}}}$$\end{document}</tex-math><mml:math id="M220"><mml:mi mathvariant="bold">V</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq108.gif"/></alternatives></inline-formula> denotes the genotype correlation matrix in FUSION <italic>Z</italic>-score statistic and genotype covariance matrix in S-PrediXcan<italic>Z</italic>-score statistic of the test SNPs. In particular, <inline-formula id="IEq109"><alternatives><tex-math id="M221">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\hat{\sigma }}_{j}$$\end{document}</tex-math><mml:math id="M222"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq109.gif"/></alternatives></inline-formula> and <inline-formula id="IEq110"><alternatives><tex-math id="M223">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{V}}}}}}$$\end{document}</tex-math><mml:math id="M224"><mml:mi mathvariant="bold">V</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq110.gif"/></alternatives></inline-formula> can be approximated from a reference panel with genotype data of samples of the same ancestry such as those available from the 1000 Genomes Project<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. If <inline-formula id="IEq111"><alternatives><tex-math id="M225">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M226"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq111.gif"/></alternatives></inline-formula> are standardized effect sizes estimated assuming standardized genotype <inline-formula id="IEq112"><alternatives><tex-math id="M227">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M228"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq112.gif"/></alternatives></inline-formula> and gene expression <inline-formula id="IEq113"><alternatives><tex-math id="M229">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M230"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq113.gif"/></alternatives></inline-formula> in Eq. (<xref rid="Equ1" ref-type="disp-formula">1</xref>), FUSION and S-PrediXcan <italic>Z</italic>-score statistics are equivalent<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Otherwise, the S-PrediXcan <italic>Z</italic>-score should be applied to avoid false-positive inflation.</p>
    </sec>
    <sec id="Sec11">
      <title>TWAS Stage I analysis using summary-level reference data</title>
      <p id="Par42">We now consider a variation of TWAS Stage I to estimate cis-eQTL effect sizes <inline-formula id="IEq114"><alternatives><tex-math id="M231">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M232"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq114.gif"/></alternatives></inline-formula> based on a multivariable regression model (Eq. (<xref rid="Equ1" ref-type="disp-formula">1</xref>)) from summary-level reference data. We assume that the summary-level reference data provide information on the association between a single genetic variant <italic>j</italic> (<inline-formula id="IEq115"><alternatives><tex-math id="M233">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$j=1,\ldots,m$$\end{document}</tex-math><mml:math id="M234"><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq115.gif"/></alternatives></inline-formula>) and expression of gene <italic>g</italic>. This information generally consists of effect size estimates (<inline-formula id="IEq116"><alternatives><tex-math id="M235">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\widetilde{w}}_{j},j=1,\ldots,m$$\end{document}</tex-math><mml:math id="M236"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq116.gif"/></alternatives></inline-formula>) and <italic>p</italic> values derived from the following single variant regression models:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M237">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}={{{{{{\bf{x}}}}}}}_{j}{w}_{j}+{{{{{{\boldsymbol{\epsilon }}}}}}}_{j},{{{{{{\boldsymbol{\epsilon }}}}}}}_{j}\sim N\left(0,{\sigma }_{{\epsilon }_{j}}^{2}{{{{{\bf{I}}}}}}\right),\, j=1,\ldots,m.$$\end{document}</tex-math><mml:math id="M238"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mi mathvariant="bold">I</mml:mi></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>.</mml:mo></mml:math><graphic xlink:href="41467_2023_36862_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>Here, <inline-formula id="IEq117"><alternatives><tex-math id="M239">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{x}}}}}}}_{j}$$\end{document}</tex-math><mml:math id="M240"><mml:msub><mml:mrow><mml:mi mathvariant="bold">x</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq117.gif"/></alternatives></inline-formula> is an <inline-formula id="IEq118"><alternatives><tex-math id="M241">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n\times 1$$\end{document}</tex-math><mml:math id="M242"><mml:mi>n</mml:mi><mml:mo>×</mml:mo><mml:mn>1</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq118.gif"/></alternatives></inline-formula> vector of genotype data for genetic variant <inline-formula id="IEq119"><alternatives><tex-math id="M243">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$j$$\end{document}</tex-math><mml:math id="M244"><mml:mi>j</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq119.gif"/></alternatives></inline-formula>, and <inline-formula id="IEq120"><alternatives><tex-math id="M245">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\boldsymbol{\epsilon }}}}}}}_{j}$$\end{document}</tex-math><mml:math id="M246"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq120.gif"/></alternatives></inline-formula> is the error term. Since eQTL summary data are analogous to GWAS summary data where gene expression represents the phenotype, we can estimate the eQTL effect sizes <inline-formula id="IEq121"><alternatives><tex-math id="M247">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M248"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq121.gif"/></alternatives></inline-formula> using marginal least squared effect estimates (<inline-formula id="IEq122"><alternatives><tex-math id="M249">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\widetilde{w}}_{j},\,j=1,\ldots,m$$\end{document}</tex-math><mml:math id="M250"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq122.gif"/></alternatives></inline-formula>) and <italic>p</italic> values from the QTL summary data as well as reference LD information of the same ancestry<sup><xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR29">29</xref></sup>. Although all PRS methods apply to the TWAS Stage I framework, we only consider four representative methods as follows:</p>
      <p id="Par43">P+T<italic>:</italic> the P+T method selects eQTL weights by LD clumping and <italic>p</italic> value Thresholding<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Given threshold <inline-formula id="IEq123"><alternatives><tex-math id="M251">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${P}_{T}$$\end{document}</tex-math><mml:math id="M252"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq123.gif"/></alternatives></inline-formula> for <italic>p</italic> values and threshold <inline-formula id="IEq124"><alternatives><tex-math id="M253">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}_{T}$$\end{document}</tex-math><mml:math id="M254"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq124.gif"/></alternatives></inline-formula> for LD <inline-formula id="IEq125"><alternatives><tex-math id="M255">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M256"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq125.gif"/></alternatives></inline-formula>, we first exclude SNPs with marginal <italic>p</italic> values from eQTL summary data greater than <inline-formula id="IEq126"><alternatives><tex-math id="M257">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${P}_{T}$$\end{document}</tex-math><mml:math id="M258"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq126.gif"/></alternatives></inline-formula> or strongly correlated (LD <inline-formula id="IEq127"><alternatives><tex-math id="M259">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M260"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq127.gif"/></alternatives></inline-formula> greater than <inline-formula id="IEq128"><alternatives><tex-math id="M261">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}_{T}$$\end{document}</tex-math><mml:math id="M262"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq128.gif"/></alternatives></inline-formula>) with another SNP having a more significant marginal <italic>p</italic> value (or <italic>Z</italic>-score statistic value). For the remaining selected test SNPs, we use marginal standardized eQTL effect sizes from eQTL summary data as eQTL weights for TWAS in Stage II. We considered <inline-formula id="IEq129"><alternatives><tex-math id="M263">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}_{T}=0.99$$\end{document}</tex-math><mml:math id="M264"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.99</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq129.gif"/></alternatives></inline-formula> and <inline-formula id="IEq130"><alternatives><tex-math id="M265">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${P}_{T}=({{{{\mathrm{0.001,0.05}}}}})$$\end{document}</tex-math><mml:math id="M266"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">0.001, 0.05</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq130.gif"/></alternatives></inline-formula> in this paper and implemented the P+T method using PLINK 1.9<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> (see Code availability). We denote the P+T method with <inline-formula id="IEq131"><alternatives><tex-math id="M267">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${P}_{T}$$\end{document}</tex-math><mml:math id="M268"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq131.gif"/></alternatives></inline-formula> equal to 0.001 and 0.05 as P+T (0.001) and P+T (0.05), respectively.</p>
      <p id="Par44">Frequentist lassosum: with standardized <inline-formula id="IEq132"><alternatives><tex-math id="M269">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M270"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq132.gif"/></alternatives></inline-formula> and <inline-formula id="IEq133"><alternatives><tex-math id="M271">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M272"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq133.gif"/></alternatives></inline-formula>, we can show that the marginal least squared eQTL effect size estimates from the single variant regression model (Eq. (<xref rid="Equ3" ref-type="disp-formula">3</xref>)) is <inline-formula id="IEq134"><alternatives><tex-math id="M273">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widetilde{{{{{{\bf{w}}}}}}}{{{{{\boldsymbol{=}}}}}}{{{{{{\bf{X}}}}}}}_{g}^{{{{{{\rm{T}}}}}}}{{{{{{\bf{e}}}}}}}_{g}{{{{{\boldsymbol{/}}}}}}n$$\end{document}</tex-math><mml:math id="M274"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover><mml:mi mathvariant="bold-italic">=</mml:mi><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold-italic">/</mml:mi><mml:mi>n</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq134.gif"/></alternatives></inline-formula> and that the LD correlation matrix is <inline-formula id="IEq135"><alternatives><tex-math id="M275">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{R}}}}}}$$\end{document}</tex-math><mml:math id="M276"><mml:mi mathvariant="bold">R</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq135.gif"/></alternatives></inline-formula><bold>=</bold><inline-formula id="IEq136"><alternatives><tex-math id="M277">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}^{{{{{{\rm{T}}}}}}}{{{{{{\bf{X}}}}}}}_{g}{{{{{\boldsymbol{/}}}}}}n$$\end{document}</tex-math><mml:math id="M278"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold-italic">/</mml:mi><mml:mi>n</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq136.gif"/></alternatives></inline-formula>. That is,<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M279">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}^{{{{{{\rm{T}}}}}}}{{{{{{\bf{e}}}}}}}_{g}=n\widetilde{{{{{{\bf{w}}}}}}} \, {{{{{\rm{and}}}}}} \, {{{{{{\bf{X}}}}}}}_{g}^{{{{{{\rm{T}}}}}}}{{{{{{\bf{X}}}}}}}_{g}=n{{{{{\bf{R}}}}}}.$$\end{document}</tex-math><mml:math id="M280"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>n</mml:mi><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">and</mml:mi><mml:mspace width="0.25em"/><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>n</mml:mi><mml:mi mathvariant="bold">R</mml:mi><mml:mo>.</mml:mo></mml:math><graphic xlink:href="41467_2023_36862_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par45">By approximating <inline-formula id="IEq137"><alternatives><tex-math id="M281">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n{{{{{\bf{R}}}}}}$$\end{document}</tex-math><mml:math id="M282"><mml:mi>n</mml:mi><mml:mi mathvariant="bold">R</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq137.gif"/></alternatives></inline-formula> by <inline-formula id="IEq138"><alternatives><tex-math id="M283">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n{{{{{{\bf{R}}}}}}}_{s}$$\end{document}</tex-math><mml:math id="M284"><mml:mi>n</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="bold">R</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq138.gif"/></alternatives></inline-formula><inline-formula id="IEq139"><alternatives><tex-math id="M285">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\boldsymbol{(}}}}}}{{{{{\bf{R}}}}}}}_{s}{{{{{\boldsymbol{=}}}}}}\left(1-s\right){{{{{{\bf{R}}}}}}}_{r}+s{{{{{\bf{I}}}}}}{{{{{\boldsymbol{)}}}}}}$$\end{document}</tex-math><mml:math id="M286"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">(</mml:mi><mml:mi mathvariant="bold">R</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold-italic">=</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:mfenced><mml:msub><mml:mrow><mml:mi mathvariant="bold">R</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>s</mml:mi><mml:mi mathvariant="bold">I</mml:mi><mml:mi mathvariant="bold-italic">)</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq139.gif"/></alternatives></inline-formula> with a tuning parameter <inline-formula id="IEq140"><alternatives><tex-math id="M287">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$0 &lt; s &lt; 1$$\end{document}</tex-math><mml:math id="M288"><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>s</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq140.gif"/></alternatives></inline-formula>, a reference LD correlation matrix <inline-formula id="IEq141"><alternatives><tex-math id="M289">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{R}}}}}}}_{r}$$\end{document}</tex-math><mml:math id="M290"><mml:msub><mml:mrow><mml:mi mathvariant="bold">R</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq141.gif"/></alternatives></inline-formula> from an external panel such as one from the 1000 Genomes Project<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>, and an identity matrix <inline-formula id="IEq142"><alternatives><tex-math id="M291">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{I}}}}}}{{{{{\boldsymbol{)}}}}}}$$\end{document}</tex-math><mml:math id="M292"><mml:mi mathvariant="bold">I</mml:mi><mml:mi mathvariant="bold-italic">)</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq142.gif"/></alternatives></inline-formula> in the LASSO<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> penalized loss function, the frequentist lassosum method<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> can tune the LASSO penalty parameter and <inline-formula id="IEq143"><alternatives><tex-math id="M293">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$s$$\end{document}</tex-math><mml:math id="M294"><mml:mi>s</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq143.gif"/></alternatives></inline-formula> using a pseudovalidation approach and then solve for eQTL effect size estimates <inline-formula id="IEq144"><alternatives><tex-math id="M295">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M296"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq144.gif"/></alternatives></inline-formula> by minimizing the approximated LASSO loss function requiring no individual-level data (see details in Supplementary Methods).</p>
      <p id="Par46">Bayesian SDPR: Bayesian DPR method<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> as implemented in TIGAR<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> estimates <inline-formula id="IEq145"><alternatives><tex-math id="M297">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M298"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq145.gif"/></alternatives></inline-formula> for the underlying multivariable regression model in Eq. (<xref rid="Equ1" ref-type="disp-formula">1</xref>) by assuming a normal prior <inline-formula id="IEq146"><alternatives><tex-math id="M299">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$N(0,{\sigma }_{w}^{2})$$\end{document}</tex-math><mml:math id="M300"><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq146.gif"/></alternatives></inline-formula> for <inline-formula id="IEq147"><alternatives><tex-math id="M301">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${w}_{j}$$\end{document}</tex-math><mml:math id="M302"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq147.gif"/></alternatives></inline-formula> and a Dirichlet process prior<sup><xref ref-type="bibr" rid="CR59">59</xref></sup><inline-formula id="IEq148"><alternatives><tex-math id="M303">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${DP}(H,\alpha )$$\end{document}</tex-math><mml:math id="M304"><mml:mi>D</mml:mi><mml:mi>P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>H</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq148.gif"/></alternatives></inline-formula> for <inline-formula id="IEq149"><alternatives><tex-math id="M305">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\sigma }_{w}^{2}$$\end{document}</tex-math><mml:math id="M306"><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq149.gif"/></alternatives></inline-formula> with base distribution <inline-formula id="IEq150"><alternatives><tex-math id="M307">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$H$$\end{document}</tex-math><mml:math id="M308"><mml:mi>H</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq150.gif"/></alternatives></inline-formula> and concentration parameter <inline-formula id="IEq151"><alternatives><tex-math id="M309">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha$$\end{document}</tex-math><mml:math id="M310"><mml:mi>α</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq151.gif"/></alternatives></inline-formula>. SDPR<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> assumes the same DPR model but can be applied to estimate the eQTL effect sizes <inline-formula id="IEq152"><alternatives><tex-math id="M311">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M312"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq152.gif"/></alternatives></inline-formula> using only eQTL summary data (see details in Supplementary Methods).</p>
      <p id="Par47">Bayesian PRS-CS: the PRS-CS method<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> assumes the following normal prior for <inline-formula id="IEq153"><alternatives><tex-math id="M313">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${w}_{j}$$\end{document}</tex-math><mml:math id="M314"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq153.gif"/></alternatives></inline-formula> and non-informative scale-invariant Jeffreys prior on the residual variance <inline-formula id="IEq154"><alternatives><tex-math id="M315">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\sigma }_{\epsilon }^{2}$$\end{document}</tex-math><mml:math id="M316"><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq154.gif"/></alternatives></inline-formula> in Eq. (<xref rid="Equ1" ref-type="disp-formula">1</xref>):<disp-formula id="Equa"><alternatives><tex-math id="M317">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${w}_{j} \sim N\left(0,\frac{{\sigma }_{\epsilon }^{2}}{n}{\psi }_{j}\right),\, p\left({\sigma }_{\epsilon }^{2}\right)\propto {\sigma }_{\epsilon }^{2},\, {\psi }_{j} \sim {Gamma}\left(a,\, {\delta }_{j}\right),\, {\delta }_{j} \sim {Gamma}\left(b,\, \phi \right),$$\end{document}</tex-math><mml:math id="M318"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfenced><mml:mo>∝</mml:mo><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi>G</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi>G</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi>b</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mi>ϕ</mml:mi></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic xlink:href="41467_2023_36862_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>where local shrinkage parameter <inline-formula id="IEq155"><alternatives><tex-math id="M319">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\rm{\psi }}}}}}}_{{{{{{\rm{j}}}}}}}$$\end{document}</tex-math><mml:math id="M320"><mml:msub><mml:mrow><mml:mi mathvariant="normal">ψ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq155.gif"/></alternatives></inline-formula> has an independent gamma-gamma prior and <inline-formula id="IEq156"><alternatives><tex-math id="M321">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\phi$$\end{document}</tex-math><mml:math id="M322"><mml:mi>ϕ</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq156.gif"/></alternatives></inline-formula> is a global-shrinkage parameter controlling the overall sparsity of <inline-formula id="IEq157"><alternatives><tex-math id="M323">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{w}}}}}}$$\end{document}</tex-math><mml:math id="M324"><mml:mi mathvariant="bold">w</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq157.gif"/></alternatives></inline-formula>. PRS-CS sets hyper parameters <inline-formula id="IEq158"><alternatives><tex-math id="M325">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a=1$$\end{document}</tex-math><mml:math id="M326"><mml:mi>a</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq158.gif"/></alternatives></inline-formula> and <inline-formula id="IEq159"><alternatives><tex-math id="M327">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\rm{b}}}}}}$$\end{document}</tex-math><mml:math id="M328"><mml:mi mathvariant="normal">b</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq159.gif"/></alternatives></inline-formula> = 1/2 to ensure the prior density of <inline-formula id="IEq160"><alternatives><tex-math id="M329">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\rm{w}}}}}}}_{{{{{{\rm{j}}}}}}}$$\end{document}</tex-math><mml:math id="M330"><mml:msub><mml:mrow><mml:mi mathvariant="normal">w</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq160.gif"/></alternatives></inline-formula> to have a sharp peak around zero to shrink small effect sizes of potentially false eQTL towards zero, as well as heavy, Cauchy-like tails which assert little influence on eQTLs with larger effects. Posterior estimates <inline-formula id="IEq161"><alternatives><tex-math id="M331">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M332"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mrow><mml:mo>^</mml:mo></mml:mrow></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq161.gif"/></alternatives></inline-formula> will be obtained from eQTL summary data (i.e., marginal effect size estimates <inline-formula id="IEq162"><alternatives><tex-math id="M333">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widetilde{{{{{{\bf{w}}}}}}}$$\end{document}</tex-math><mml:math id="M334"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq162.gif"/></alternatives></inline-formula> and <italic>p</italic> values) and reference LD correlation matrix <inline-formula id="IEq163"><alternatives><tex-math id="M335">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{R}}}}}}$$\end{document}</tex-math><mml:math id="M336"><mml:mi mathvariant="bold">R</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq163.gif"/></alternatives></inline-formula> by Gibbs Sampler (see details in Supplementary Methods). We set <inline-formula id="IEq164"><alternatives><tex-math id="M337">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\phi$$\end{document}</tex-math><mml:math id="M338"><mml:mi>ϕ</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq164.gif"/></alternatives></inline-formula> as the square of the proportion of causal variants in the simulation and as <inline-formula id="IEq165"><alternatives><tex-math id="M339">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${10}^{-4}$$\end{document}</tex-math><mml:math id="M340"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq165.gif"/></alternatives></inline-formula> per gene in the real data application.</p>
    </sec>
    <sec id="Sec12">
      <title>OTTERS framework</title>
      <p id="Par48">As shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>, OTTERS first trains GReX imputation models per gene <italic>g</italic> using P+T, lassosum, SDPR, and PRS-CS methods that each infers cis-eQTLs weights using cis-eQTL summary data and an external LD reference panel of similar ancestry (Stage I). Once we derive cis-eQTLs weights for each training method, we can impute the respective GReX using that method and perform the respective gene-based association analysis in the test GWAS dataset using the formulas given in Eq. (<xref rid="Equ2" ref-type="disp-formula">2</xref>) (Stage II). We thus derive a set of TWAS <italic>p</italic> values for gene <italic>g</italic>; one <italic>p</italic> value for each training model that we applied. We then use these TWAS <italic>p</italic> values to create an omnibus test using the ACAT-O<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> approach that employs a Cauchy distribution for inference (see details in Supplementary Methods). We refer to the <italic>p</italic> value derived from ACAT-O test as the OTTERS <italic>p</italic> value.</p>
    </sec>
    <sec id="Sec13">
      <title>Marginal eQTL effect sizes</title>
      <p id="Par49">In practice of training GReX imputation models using reference eQTL summary data, the marginal standardized eQTL effect sizes were approximated by <inline-formula id="IEq166"><alternatives><tex-math id="M341">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\widetilde{{{{{{\rm{w}}}}}}}}_{j} \, \approx \, {Z}_{j}/\sqrt{{{{{{\rm{median}}}}}}(n_{g,j})}$$\end{document}</tex-math><mml:math id="M342"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">w</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mspace width="0.25em"/><mml:mo>≈</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msqrt><mml:mrow><mml:mi mathvariant="normal">median</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msqrt></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq166.gif"/></alternatives></inline-formula>, where <inline-formula id="IEq167"><alternatives><tex-math id="M343">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${Z}_{j}$$\end{document}</tex-math><mml:math id="M344"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq167.gif"/></alternatives></inline-formula> denotes the corresponding eQTL <italic>Z</italic>-score statistic value by single variant test and <inline-formula id="IEq168"><alternatives><tex-math id="M345">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\rm{median}}}}}}}(n_{g,j})$$\end{document}</tex-math><mml:math id="M346"><mml:mi mathvariant="normal">median</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq168.gif"/></alternatives></inline-formula> denotes the median sample size of all cis-eQTLs for the target gene <inline-formula id="IEq169"><alternatives><tex-math id="M347">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$g$$\end{document}</tex-math><mml:math id="M348"><mml:mi>g</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq169.gif"/></alternatives></inline-formula>. The median cis-eQTL sample size per gene was also taken as the sample size value required by lassosum, SDPR, and PRS-CS methods, for robust performance. Since summary eQTL datasets (e.g., eQTLGen) were generally obtained by meta-analysis of multiple cohorts, the sample size per test SNP could vary across all cis-eQTLs of the test gene. The median cis-eQTL sample size ensures a robust performance for applying those eQTL summary data-based methods.</p>
    </sec>
    <sec id="Sec14">
      <title>LD clumping</title>
      <p id="Par50">We performed LD clumping with <inline-formula id="IEq170"><alternatives><tex-math id="M349">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$R_{T}$$\end{document}</tex-math><mml:math id="M350"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq170.gif"/></alternatives></inline-formula> = 0.99 for all individual methods in both simulation and real studies. Using PRS-CS as an example, we also showed that LD clumping does not affect the GReX imputation accuracy compared to no clumping in real data testing (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S12</xref>).</p>
    </sec>
    <sec id="Sec15">
      <title>LD blocks for lassosum, PRS-CS, and SDPR</title>
      <p id="Par51">LD blocks were determined externally by ldetect<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> for lassosum and PRS-CS, while internally for SDPR, which ensures that SNPs in one LD block do not have nonignorable correlation (<inline-formula id="IEq171"><alternatives><tex-math id="M351">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}$$\end{document}</tex-math><mml:math id="M352"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq171.gif"/></alternatives></inline-formula> &gt; 0.1) with SNPs in other blocks.</p>
    </sec>
    <sec id="Sec16">
      <title>Simulate GWAS <italic>Z</italic>-score</title>
      <p id="Par52">Given gene expression <inline-formula id="IEq172"><alternatives><tex-math id="M353">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M354"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq172.gif"/></alternatives></inline-formula> simulated from the multivariate regression model <inline-formula id="IEq173"><alternatives><tex-math id="M355">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{e}}}}}}}_{g}={{{{{{\bf{X}}}}}}}_{g}{{{{{\bf{w}}}}}}+{{{{{{\boldsymbol{\epsilon }}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M356"><mml:msub><mml:mrow><mml:mi mathvariant="bold">e</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">w</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq173.gif"/></alternatives></inline-formula> with standardized genotype matrix <inline-formula id="IEq174"><alternatives><tex-math id="M357">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M358"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq174.gif"/></alternatives></inline-formula> and <inline-formula id="IEq175"><alternatives><tex-math id="M359">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\boldsymbol{\epsilon }}}}}}}_{g}\sim N\left(0,\, (1-{h}_{e}^{2}){{{{{\bf{I}}}}}}\right.$$\end{document}</tex-math><mml:math id="M360"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi>N</mml:mi><mml:mfenced open="("><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi mathvariant="bold">I</mml:mi></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq175.gif"/></alternatives></inline-formula>, we assume GWAS phenotype data of <inline-formula id="IEq176"><alternatives><tex-math id="M361">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${n}_{{gwas}}$$\end{document}</tex-math><mml:math id="M362"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq176.gif"/></alternatives></inline-formula> samples are simulated from the following linear regression model<disp-formula id="Equb"><alternatives><tex-math id="M363">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{\bf{y}}}}}}={h}_{p}\left({{{{{{\bf{X}}}}}}}_{g}{{{{{\bf{w}}}}}}\right)+{{{{{{\boldsymbol{\epsilon }}}}}}}_{p},\, {{{{{{\boldsymbol{\epsilon }}}}}}}_{p}\sim N\left(0,{{{{{\bf{I}}}}}}\right){{{{{\boldsymbol{.}}}}}}$$\end{document}</tex-math><mml:math id="M364"><mml:mi mathvariant="bold">y</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">w</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant="bold">I</mml:mi></mml:mrow></mml:mfenced><mml:mi mathvariant="bold-italic">.</mml:mi></mml:math><graphic xlink:href="41467_2023_36862_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par53">Conditioning on true genetic effect sizes, the GWAS <italic>Z</italic>-score test statistics of all test SNPs will follow a multivariate normal distribution, <inline-formula id="IEq177"><alternatives><tex-math id="M365">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${MVN}\left({{{{{{\bf{\Sigma }}}}}}}_{g}{{{{{\bf{w}}}}}}\sqrt{{n}_{{gwas}}{h}_{p}^{2}},{{{{{{\bf{\Sigma }}}}}}}_{g}\right),$$\end{document}</tex-math><mml:math id="M366"><mml:mi>M</mml:mi><mml:mi>V</mml:mi><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">Σ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">w</mml:mi><mml:msqrt><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:msqrt><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">Σ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq177.gif"/></alternatives></inline-formula> where <inline-formula id="IEq178"><alternatives><tex-math id="M367">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{\Sigma }}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M368"><mml:msub><mml:mrow><mml:mi mathvariant="bold">Σ</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq178.gif"/></alternatives></inline-formula> is the correlation matrix of the standardized genotype <inline-formula id="IEq179"><alternatives><tex-math id="M369">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\bf{X}}}}}}}_{g}$$\end{document}</tex-math><mml:math id="M370"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq179.gif"/></alternatives></inline-formula> from test samples, and <inline-formula id="IEq180"><alternatives><tex-math id="M371">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{p}^{2}$$\end{document}</tex-math><mml:math id="M372"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq180.gif"/></alternatives></inline-formula> denotes the amount of phenotypic variance explained by simulated <inline-formula id="IEq181"><alternatives><tex-math id="M373">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{{{{\rm{GReX}}}}}}={{{{{\bf{X}}}}}}}_{g}{{{{{\bf{w}}}}}}$$\end{document}</tex-math><mml:math id="M374"><mml:msub><mml:mrow><mml:mi mathvariant="normal">GReX</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">w</mml:mi></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq181.gif"/></alternatives></inline-formula><sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Thus, for a given GWAS sample size, we can generate GWAS <italic>Z</italic>-score statistic values from this multivariate normal distribution.</p>
    </sec>
    <sec id="Sec17">
      <title>FUSION using individual-level reference data</title>
      <p id="Par54">To train GReX imputation models by FUSION with individual-level reference data, we trained Best Linear Unbiased Predictor model<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, Elastic-net regression<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, LASSO regression<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, and single best eQTL model as implemented in the FUSION tool (see Code availability). Default settings were used to train GReX imputation models by FUSION in our simulation and real studies. LASSO regression was performed only for genes with positively estimated expression heritability. The eQTL weights of the best-trained GReX imputation model will be used to conduct TWAS by FUSION.</p>
    </sec>
    <sec id="Sec18">
      <title>GTEx V8 dataset</title>
      <p id="Par55">GTEx V8 dataset (dbGaP phs000424.v8.p2) contains comprehensive profiling of WGS genotype data and RNA-sequencing (RNA-seq) transcriptomic data across 54 human tissue types of 838 donors. The GTEx V8 WGS genotype data of all samples were used to construct reference LD in our studies. The GTEx V6 RNA-seq data of whole blood samples were used to train GReX imputation models by FUSION, and the GTEx V8 RNA-seq data of additional whole blood samples (<italic>n</italic> = 315) were used to test GReX imputation accuracy in our studies. GTEx V8 RNA-seq data of all whole blood samples (<italic>n</italic> = 574) were also used as reference data for comparing the performance of OTTERS and FUSION.</p>
    </sec>
    <sec id="Sec19">
      <title>eQTLGen consortium dataset</title>
      <p id="Par56">The eQTLGen consortium<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> dataset was generated based on meta-analysis across 37 individual cohorts (<italic>n</italic> = 31,684) including GTEx V6 as a sub-cohort. eQTLGen samples consist of 25,482 blood (80.4%) and 6202 peripheral blood mononuclear cell (19.6%) samples. We considered SNPs with minor allele frequency &gt; 0.01, Hardy–Weinberg <italic>p</italic> value &gt; 0.0001, call rate &gt; 0.95, genotype imputation <inline-formula id="IEq182"><alternatives><tex-math id="M375">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${r}^{2}$$\end{document}</tex-math><mml:math id="M376"><mml:msup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2023_36862_Article_IEq182.gif"/></alternatives></inline-formula> &gt; 0.5 and observed in at least two cohorts<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. We only considered cis-eQTL (within ±1 MB around gene transcription start sites) with a test sample size &gt; 3000. As a result, we used cis-eQTL summary data of 16,699 genes from eQTLGen to train GReX imputation models for use in OTTERS in this study.</p>
    </sec>
    <sec id="Sec20">
      <title>UK Biobank GWAS data of cardiovascular disease</title>
      <p id="Par57">Summary-level GWAS data of Cardiovascular Disease from UKBB (<italic>n</italic> = 459,324, case fraction = 0.319)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> were generated by BOLT-LMM based on the Bayesian linear mixed model per SNP<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> with assessment centered, sex, age, and squared age as covariates. Although BOLT-LMM was derived based on a quantitative trait model, it can be applied to analyze case–control traits and has a well-controlled false-positive rate when the trait is sufficiently balanced with a case fraction ≥10% and samples are of the same ancestry. The tested dichotomous cardiovascular disease phenotype includes a list of sub-phenotypes: hypertension, heart/cardiac problem, peripheral vascular disease, venous thromboembolic disease, stroke, transient ischemic attack (tia), subdural hemorrhage/hematoma, cerebral aneurysm, high cholesterol, and other venous/lymphatic diseases.</p>
    </sec>
    <sec id="Sec21">
      <title>Reporting summary</title>
      <p id="Par58">Further information on research design is available in the <xref rid="MOESM3" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec22">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41467_2023_36862_MOESM1_ESM.pdf">
            <caption>
              <p>Supplementary Information</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="41467_2023_36862_MOESM2_ESM.pdf">
            <caption>
              <p>Peer Review File</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="41467_2023_36862_MOESM3_ESM.pdf">
            <caption>
              <p>Reporting Summary</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>A list of authors and their affiliations appears at the end of the paper.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p>The online version contains supplementary material available at 10.1038/s41467-023-36862-w.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>The authors thank Dr Greg Gibson from Georgia Tech for his insightful comments and discussion that help the development and improve the quality of this manuscript. This work was supported by National Institutes of Health grant awards R35GM138313 (Q.D., J.Y.), RF1AG071170 (Q.D., M.P.E.), and Estonian Research Council Grant PUT (PRG1291) for T.E. NIH/NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, R01AG56352, U01AG32984, U01AG46152, U01AG61356, the Illinois Department of Public Health, the Translational Genomics Research Institute support the generation of the ROS/MAP data led by A.S.B., P.L.D.J. and D.A.B. The Young Finns Study has been financially supported by the Academy of Finland: grants 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 255381, 256474, 283115, 319060, 320297, 314389, 338395, 330809, and 104821, 129378 (Salve), 117797 (Gendi), and 141071 (Skidi), the Social Insurance Institution of Finland, Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (grant X51001), Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation for Cardiovascular Research, Finnish Cultural Foundation, The Sigrid Juselius Foundation, Tampere Tuberculosis Foundation, Emil Aaltonen Foundation, Yrjö Jahnsson Foundation, Signe and Ane Gyllenberg Foundation, Diabetes Research Foundation of Finnish Diabetes Association, EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848146 for To Aition), European Research Council (grant 742927 for MULTIEPIGEN project), Tampere University Hospital Supporting Foundation, and Finnish Society of Clinical Chemistry and the Cancer Foundation Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>Q.D. conducted data analysis and drafted the manuscript. J.Y. and M.P.E. conceptualized and led the project, and edited the manuscript. G.Z. and H.Z. consulted data analysis and edited the manuscript. U.V., L.F., A.B., A.T., T.L., O.R. and T.E. contributed reference eQTL summary data and edited the manuscript. eQTLGen Consortium contributed eQTLGen summary data.</p>
  </notes>
  <notes notes-type="peer-review">
    <title>Peer review</title>
    <sec id="FPar1">
      <title>Peer review information</title>
      <p id="Par59"><italic>Nature Communications</italic> thanks the anonymous reviewers for their contribution to the peer review of this work. <xref rid="MOESM2" ref-type="media">Peer reviewer reports</xref> are available.</p>
    </sec>
  </notes>
  <notes notes-type="data-availability">
    <title>Data availability</title>
    <p>ROS/MAP/MSBB WGS data used in our simulation studies are available through Synapse with data access application (<ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn10901595">https://www.synapse.org/#!Synapse:syn10901595</ext-link>). The eQTLGen consortium data are available from the consortium portal website (<ext-link ext-link-type="uri" xlink:href="https://www.eqtlgen.org">https://www.eqtlgen.org</ext-link>). UK Biobank summary-level GWAS data are available through the Alkes Group (<ext-link ext-link-type="uri" xlink:href="https://alkesgroup.broadinstitute.org/UKBB">https://alkesgroup.broadinstitute.org/UKBB</ext-link>). Individual-level GTEx reference data are available through dbGap (Accession phs000424.v8.p2). Summary eQTL data of blood tissue in GTEx cohort are available from GTEx Portal (<ext-link ext-link-type="uri" xlink:href="https://console.cloud.google.com/storage/browser/gtex-resources/GTEx_Analysis_v8_QTLs/GTEx_Analysis_v8_eQTL_all_associations">https://console.cloud.google.com/storage/browser/gtex-resources/GTEx_Analysis_v8_QTLs/GTEx_Analysis_v8_eQTL_all_associations</ext-link>). Significant genes from TWAS-hub are available from <ext-link ext-link-type="uri" xlink:href="http://twas-hub.org">http://twas-hub.org</ext-link>. The summary eQTL weights of blood tissue generated by OTTERS (from eQTLGen data) and summary TWAS results generated by OTTERS for cardiovascular disease (from UK Biobank data) are available from Synapse (10.7303/syn51009573).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Code availability</title>
    <p>Source code for OTTERS is available from <ext-link ext-link-type="uri" xlink:href="https://github.com/daiqile96/OTTERS">https://github.com/daiqile96/OTTERS</ext-link>. All scripts used to generate intermediate or final data and figures are available from GitHub page <ext-link ext-link-type="uri" xlink:href="https://github.com/daiqile96/OTTERS_paper">https://github.com/daiqile96/OTTERS_paper</ext-link> and available in Zenodo with the identifier 10.5281/zenodo.7566827. Source code for ACAT is available from <ext-link ext-link-type="uri" xlink:href="https://github.com/yaowuliu/ACAT">https://github.com/yaowuliu/ACAT</ext-link>. Source code for FUSION is available from <ext-link ext-link-type="uri" xlink:href="http://gusevlab.org/projects/fusion">http://gusevlab.org/projects/fusion</ext-link>. Source code for lassosum is available from <ext-link ext-link-type="uri" xlink:href="https://github.com/tshmak/lassosum">https://github.com/tshmak/lassosum</ext-link>. Source code for PRS-CS is available from <ext-link ext-link-type="uri" xlink:href="https://github.com/getian107/PRScs">https://github.com/getian107/PRScs</ext-link>. Source code for SDPR is available from <ext-link ext-link-type="uri" xlink:href="https://github.com/eldronzhou/SDPR">https://github.com/eldronzhou/SDPR</ext-link>. Plink version 1.9 is used and available at <ext-link ext-link-type="uri" xlink:href="https://www.cog-genomics.org/plink/">https://www.cog-genomics.org/plink/</ext-link>.</p>
  </notes>
  <notes id="FPar2" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par60">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mancuso</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrating gene expression with summary association statistics to identify genes associated with 30 complex traits</article-title>
        <source>Am. J. Hum. Genet.</source>
        <year>2017</year>
        <volume>100</volume>
        <fpage>473</fpage>
        <lpage>487</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.01.031</pub-id>
        <?supplied-pmid 28238358?>
        <pub-id pub-id-type="pmid">28238358</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gusev</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights</article-title>
        <source>Nat. Genet.</source>
        <year>2018</year>
        <volume>50</volume>
        <fpage>538</fpage>
        <lpage>548</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-018-0092-1</pub-id>
        <?supplied-pmid 29632383?>
        <pub-id pub-id-type="pmid">29632383</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mancuso</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Large-scale transcriptome-wide association study identifies new prostate cancer risk regions</article-title>
        <source>Nat. Commun.</source>
        <year>2018</year>
        <volume>9</volume>
        <fpage>4079</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-018-06302-1</pub-id>
        <?supplied-pmid 30287866?>
        <pub-id pub-id-type="pmid">30287866</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wainberg</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Opportunities and challenges for transcriptome-wide association studies</article-title>
        <source>Nat. Genet.</source>
        <year>2019</year>
        <volume>51</volume>
        <fpage>592</fpage>
        <lpage>599</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0385-z</pub-id>
        <?supplied-pmid 30926968?>
        <pub-id pub-id-type="pmid">30926968</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Strunz</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lauwen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kiel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hollander</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Weber</surname>
            <given-names>BHF</given-names>
          </name>
        </person-group>
        <article-title>A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration</article-title>
        <source>Sci. Rep.</source>
        <year>2020</year>
        <volume>10</volume>
        <fpage>1584</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-020-58510-9</pub-id>
        <?supplied-pmid 32005911?>
        <pub-id pub-id-type="pmid">32005911</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raj</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility</article-title>
        <source>Nat. Genet.</source>
        <year>2018</year>
        <volume>50</volume>
        <fpage>1584</fpage>
        <lpage>1592</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-018-0238-1</pub-id>
        <?supplied-pmid 30297968?>
        <pub-id pub-id-type="pmid">30297968</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hao</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Prediction of Alzheimer’s disease-associated genes by integration of GWAS summary data and expression data</article-title>
        <source>Front. Genet.</source>
        <year>2019</year>
        <volume>9</volume>
        <fpage>653</fpage>
        <pub-id pub-id-type="doi">10.3389/fgene.2018.00653</pub-id>
        <?supplied-pmid 30666269?>
        <pub-id pub-id-type="pmid">30666269</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luningham</surname>
            <given-names>JM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Bayesian genome-wide TWAS method to leverage both cis- and trans-eQTL information through summary statistics</article-title>
        <source>Am. J. Hum. Genet.</source>
        <year>2020</year>
        <volume>107</volume>
        <fpage>714</fpage>
        <lpage>726</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2020.08.022</pub-id>
        <?supplied-pmid 32961112?>
        <pub-id pub-id-type="pmid">32961112</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hoffman</surname>
            <given-names>JD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cis-eQTL-basedtrans-ethnic meta-analysis reveals novel genes associated with breast cancer risk</article-title>
        <source>PLoS Genet.</source>
        <year>2017</year>
        <volume>13</volume>
        <fpage>e1006690</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1006690</pub-id>
        <?supplied-pmid 28362817?>
        <pub-id pub-id-type="pmid">28362817</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer</article-title>
        <source>Nat. Genet.</source>
        <year>2018</year>
        <volume>50</volume>
        <fpage>968</fpage>
        <lpage>978</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-018-0132-x</pub-id>
        <?supplied-pmid 29915430?>
        <pub-id pub-id-type="pmid">29915430</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bhattacharya</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A framework for transcriptome-wide association studies in breast cancer in diverse study populations</article-title>
        <source>Genome Biol.</source>
        <year>2020</year>
        <volume>21</volume>
        <fpage>42</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-020-1942-6</pub-id>
        <?supplied-pmid 32079541?>
        <pub-id pub-id-type="pmid">32079541</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gusev</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants</article-title>
        <source>Nat. Genet.</source>
        <year>2019</year>
        <volume>51</volume>
        <fpage>815</fpage>
        <lpage>823</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0395-x</pub-id>
        <?supplied-pmid 31043753?>
        <pub-id pub-id-type="pmid">31043753</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Parrish</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>GC</given-names>
          </name>
          <name>
            <surname>Epstein</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>TIGAR-V2: efficient TWAS tool with nonparametric Bayesian eQTL weights of 49 tissue types from GTEx V8</article-title>
        <source>HGG Adv.</source>
        <year>2022</year>
        <volume>3</volume>
        <fpage>100068</fpage>
        <?supplied-pmid 35047855?>
        <pub-id pub-id-type="pmid">35047855</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thériault</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic association analyses highlight IL6, ALPL, and NAV1 As 3 new susceptibility genes underlying calcific aortic valve stenosis</article-title>
        <source>Circ. Genom. Precis. Med.</source>
        <year>2019</year>
        <volume>12</volume>
        <fpage>e002617</fpage>
        <pub-id pub-id-type="doi">10.1161/CIRCGEN.119.002617</pub-id>
        <?supplied-pmid 32141789?>
        <pub-id pub-id-type="pmid">32141789</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic overlap of chronic obstructive pulmonary disease and cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis</article-title>
        <source>Respir. Res.</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>64</fpage>
        <pub-id pub-id-type="doi">10.1186/s12931-019-1036-8</pub-id>
        <?supplied-pmid 30940143?>
        <pub-id pub-id-type="pmid">30940143</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lonsdale</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Genotype-Tissue Expression (GTEx) project</article-title>
        <source>Nat. Genet.</source>
        <year>2013</year>
        <volume>45</volume>
        <fpage>580</fpage>
        <lpage>585</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2653</pub-id>
        <pub-id pub-id-type="pmid">23715323</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>THE GTEx Consortium.</collab>
        </person-group>
        <article-title>The GTEx Consortium atlas of genetic regulatory effects across human tissues</article-title>
        <source>Science</source>
        <year>2020</year>
        <volume>369</volume>
        <fpage>1318</fpage>
        <lpage>1330</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aaz1776</pub-id>
        <pub-id pub-id-type="pmid">32913098</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gibbs</surname>
            <given-names>JR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain</article-title>
        <source>PLoS Genet.</source>
        <year>2010</year>
        <volume>6</volume>
        <fpage>e1000952</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1000952</pub-id>
        <?supplied-pmid 20485568?>
        <pub-id pub-id-type="pmid">20485568</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gamazon</surname>
            <given-names>ER</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A gene-based association method for mapping traits using reference transcriptome data</article-title>
        <source>Nat. Genet.</source>
        <year>2015</year>
        <volume>47</volume>
        <fpage>1091</fpage>
        <lpage>1098</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3367</pub-id>
        <?supplied-pmid 26258848?>
        <pub-id pub-id-type="pmid">26258848</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gusev</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrative approaches for large-scale transcriptome-wide association studies</article-title>
        <source>Nat. Genet.</source>
        <year>2016</year>
        <volume>48</volume>
        <fpage>245</fpage>
        <lpage>252</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3506</pub-id>
        <?supplied-pmid 26854917?>
        <pub-id pub-id-type="pmid">26854917</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer’s dementia</article-title>
        <source>PLoS Genet.</source>
        <year>2021</year>
        <volume>17</volume>
        <fpage>e1009482</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1009482</pub-id>
        <?supplied-pmid 33798195?>
        <pub-id pub-id-type="pmid">33798195</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nagpal</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TIGAR: an improved Bayesian tool for transcriptomic data imputation enhances gene mapping of complex traits</article-title>
        <source>Am. J. Hum. Genet.</source>
        <year>2019</year>
        <volume>105</volume>
        <fpage>258</fpage>
        <lpage>266</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2019.05.018</pub-id>
        <?supplied-pmid 31230719?>
        <pub-id pub-id-type="pmid">31230719</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Võsa</surname>
            <given-names>U</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression</article-title>
        <source>Nat. Genet.</source>
        <year>2021</year>
        <volume>53</volume>
        <fpage>1300</fpage>
        <lpage>1310</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-021-00913-z</pub-id>
        <?supplied-pmid 34475573?>
        <pub-id pub-id-type="pmid">34475573</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>The CommonMind Consortium (CMC)</collab>
          <etal/>
        </person-group>
        <article-title>Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions</article-title>
        <source>Sci. Data</source>
        <year>2020</year>
        <volume>7</volume>
        <fpage>340</fpage>
        <pub-id pub-id-type="doi">10.1038/s41597-020-00642-8</pub-id>
        <pub-id pub-id-type="pmid">33046718</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Power analysis of transcriptome-wide association study: Implications for practical protocol choice</article-title>
        <source>PLoS Genet.</source>
        <year>2021</year>
        <volume>17</volume>
        <fpage>e1009405</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1009405</pub-id>
        <?supplied-pmid 33635859?>
        <pub-id pub-id-type="pmid">33635859</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Purcell</surname>
            <given-names>SM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</article-title>
        <source>Nature</source>
        <year>2009</year>
        <volume>460</volume>
        <fpage>748</fpage>
        <lpage>752</lpage>
        <pub-id pub-id-type="doi">10.1038/nature08185</pub-id>
        <?supplied-pmid 19571811?>
        <pub-id pub-id-type="pmid">19571811</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mak</surname>
            <given-names>TSH</given-names>
          </name>
          <name>
            <surname>Porsch</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Sham</surname>
            <given-names>PC</given-names>
          </name>
        </person-group>
        <article-title>Polygenic scores via penalized regression on summary statistics</article-title>
        <source>Genet. Epidemiol.</source>
        <year>2017</year>
        <volume>41</volume>
        <fpage>469</fpage>
        <lpage>480</lpage>
        <pub-id pub-id-type="doi">10.1002/gepi.22050</pub-id>
        <?supplied-pmid 28480976?>
        <pub-id pub-id-type="pmid">28480976</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ge</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C-Y</given-names>
          </name>
          <name>
            <surname>Ni</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Y-CA</given-names>
          </name>
          <name>
            <surname>Smoller</surname>
            <given-names>JW</given-names>
          </name>
        </person-group>
        <article-title>Polygenic prediction via Bayesian regression and continuous shrinkage priors</article-title>
        <source>Nat. Commun.</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>1776</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-019-09718-5</pub-id>
        <?supplied-pmid 30992449?>
        <pub-id pub-id-type="pmid">30992449</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>A fast and robust Bayesian nonparametric method for prediction of complex traits using summary statistics</article-title>
        <source>PLoS Genet.</source>
        <year>2021</year>
        <volume>17</volume>
        <fpage>e1009697</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1009697</pub-id>
        <?supplied-pmid 34310601?>
        <pub-id pub-id-type="pmid">34310601</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Privé</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Vilhjálmsson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Speed</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Improved genetic prediction of complex traits from individual-level data or summary statistics</article-title>
        <source>Nat. Commun.</source>
        <year>2021</year>
        <volume>12</volume>
        <fpage>4192</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-021-24485-y</pub-id>
        <?supplied-pmid 34234142?>
        <pub-id pub-id-type="pmid">34234142</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PUMAS: fine-tuning polygenic risk scores with GWAS summary statistics</article-title>
        <source>Genome Biol.</source>
        <year>2021</year>
        <volume>22</volume>
        <fpage>257</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-021-02479-9</pub-id>
        <?supplied-pmid 34488838?>
        <pub-id pub-id-type="pmid">34488838</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tibshirani</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Regression shrinkage and selection via the lasso</article-title>
        <source>J. R. Stat. Soc.: Ser. B Methodol.</source>
        <year>1996</year>
        <volume>58</volume>
        <fpage>267</fpage>
        <lpage>288</lpage>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Non-parametric genetic prediction of complex traits with latent Dirichlet process regression models</article-title>
        <source>Nat. Commun.</source>
        <year>2017</year>
        <volume>8</volume>
        <fpage>456</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-017-00470-2</pub-id>
        <?supplied-pmid 28878256?>
        <pub-id pub-id-type="pmid">28878256</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ACAT: a fast and powerful p value combination method for rare-variant analysis in sequencing studies</article-title>
        <source>Am. J. Hum. Genet.</source>
        <year>2019</year>
        <volume>104</volume>
        <fpage>410</fpage>
        <lpage>421</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2019.01.002</pub-id>
        <?supplied-pmid 30849328?>
        <pub-id pub-id-type="pmid">30849328</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Loh</surname>
            <given-names>P-R</given-names>
          </name>
          <name>
            <surname>Kichaev</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gazal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schoech</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Price</surname>
            <given-names>AL</given-names>
          </name>
        </person-group>
        <article-title>Mixed-model association for biobank-scale datasets</article-title>
        <source>Nat. Genet.</source>
        <year>2018</year>
        <volume>50</volume>
        <fpage>906</fpage>
        <lpage>908</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-018-0144-6</pub-id>
        <?supplied-pmid 29892013?>
        <pub-id pub-id-type="pmid">29892013</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gamazon</surname>
            <given-names>ER</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A gene-based association method for mapping traits using reference transcriptome data</article-title>
        <source>Nat. Genet.</source>
        <year>2015</year>
        <volume>47</volume>
        <fpage>1091</fpage>
        <lpage>1098</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3367</pub-id>
        <?supplied-pmid 26258848?>
        <pub-id pub-id-type="pmid">26258848</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale</article-title>
        <source>Nat. Genet.</source>
        <year>2020</year>
        <volume>52</volume>
        <fpage>969</fpage>
        <lpage>983</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-020-0676-4</pub-id>
        <?supplied-pmid 32839606?>
        <pub-id pub-id-type="pmid">32839606</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Leveraging expression from multiple tissues using sparse canonical correlation analysis and aggregate tests improves the power of transcriptome-wide association studies</article-title>
        <source>PLoS Genet.</source>
        <year>2021</year>
        <volume>17</volume>
        <fpage>e1008973</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1008973</pub-id>
        <?supplied-pmid 33831007?>
        <pub-id pub-id-type="pmid">33831007</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <mixed-citation publication-type="other">Wang, T., Ionita-Laza, I. &amp; Wei, Y. Integrated Quantile RAnk Test (iQRAT) for gene-level associations. <italic>Ann. Appl. Stat</italic>. <bold>16</bold>, 1423–1444 (2022).</mixed-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bennett</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Arvanitakis</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>RS</given-names>
          </name>
        </person-group>
        <article-title>Overview and findings from the religious orders study</article-title>
        <source>Curr. Alzheimer Res.</source>
        <year>2012</year>
        <volume>9</volume>
        <fpage>628</fpage>
        <lpage>645</lpage>
        <pub-id pub-id-type="doi">10.2174/156720512801322573</pub-id>
        <?supplied-pmid 22471860?>
        <pub-id pub-id-type="pmid">22471860</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bennett</surname>
            <given-names>DA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Religious orders study and rush memory and aging project</article-title>
        <source>J. Alzheimers Dis.</source>
        <year>2018</year>
        <volume>64</volume>
        <fpage>S161</fpage>
        <lpage>S189</lpage>
        <pub-id pub-id-type="doi">10.3233/JAD-179939</pub-id>
        <?supplied-pmid 29865057?>
        <pub-id pub-id-type="pmid">29865057</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer’s disease</article-title>
        <source>Sci. Data</source>
        <year>2018</year>
        <volume>5</volume>
        <fpage>180185</fpage>
        <pub-id pub-id-type="doi">10.1038/sdata.2018.185</pub-id>
        <?supplied-pmid 30204156?>
        <pub-id pub-id-type="pmid">30204156</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bhattacharya</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Love</surname>
            <given-names>MI</given-names>
          </name>
        </person-group>
        <article-title>MOSTWAS: Multi-Omic Strategies for Transcriptome-Wide Association Studies</article-title>
        <source>PLoS Genet.</source>
        <year>2021</year>
        <volume>17</volume>
        <fpage>e1009398</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1009398</pub-id>
        <?supplied-pmid 33684137?>
        <pub-id pub-id-type="pmid">33684137</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Battle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Engelhardt</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Montgomery</surname>
            <given-names>SB</given-names>
          </name>
        </person-group>
        <article-title>Genetic effects on gene expression across human tissues</article-title>
        <source>Nature</source>
        <year>2017</year>
        <volume>550</volume>
        <fpage>204</fpage>
        <lpage>213</lpage>
        <pub-id pub-id-type="doi">10.1038/nature24277</pub-id>
        <?supplied-pmid 29022597?>
        <pub-id pub-id-type="pmid">29022597</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Devlin</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Roeder</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wasserman</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Genomic control, a new approach to genetic-based association studies</article-title>
        <source>Theor. Popul. Biol.</source>
        <year>2001</year>
        <volume>60</volume>
        <fpage>155</fpage>
        <lpage>166</lpage>
        <pub-id pub-id-type="doi">10.1006/tpbi.2001.1542</pub-id>
        <?supplied-pmid 11855950?>
        <pub-id pub-id-type="pmid">11855950</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fuchs</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Whelton</surname>
            <given-names>PK</given-names>
          </name>
        </person-group>
        <article-title>High blood pressure and cardiovascular disease</article-title>
        <source>Hypertension</source>
        <year>2020</year>
        <volume>75</volume>
        <fpage>285</fpage>
        <lpage>292</lpage>
        <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.14240</pub-id>
        <?supplied-pmid 31865786?>
        <pub-id pub-id-type="pmid">31865786</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Masaki</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>The endothelin family: an overview</article-title>
        <source>J. Cardiovasc Pharm.</source>
        <year>2000</year>
        <volume>35</volume>
        <fpage>S3</fpage>
        <lpage>S5</lpage>
        <pub-id pub-id-type="doi">10.1097/00005344-200000002-00002</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xue</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>W</given-names>
          </name>
          <collab>Alzheimer’s Disease Neuroimaging Initiative.</collab>
        </person-group>
        <article-title>Some statistical consideration in transcriptome-wide association studies</article-title>
        <source>Genet. Epidemiol.</source>
        <year>2020</year>
        <volume>44</volume>
        <fpage>221</fpage>
        <lpage>232</lpage>
        <pub-id pub-id-type="doi">10.1002/gepi.22274</pub-id>
        <?supplied-pmid 31821608?>
        <pub-id pub-id-type="pmid">31821608</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>HM</given-names>
          </name>
        </person-group>
        <article-title>Meta-imputation of transcriptome from genotypes across multiple datasets by leveraging publicly available summary-level data</article-title>
        <source>PLoS Genet.</source>
        <year>2022</year>
        <volume>18</volume>
        <fpage>e1009571</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1009571</pub-id>
        <?supplied-pmid 35100255?>
        <pub-id pub-id-type="pmid">35100255</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CoMM-S2: a collaborative mixed model using summary statistics in transcriptome-wide association studies</article-title>
        <source>Bioinformatics</source>
        <year>2020</year>
        <volume>36</volume>
        <fpage>2009</fpage>
        <lpage>2016</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btz880</pub-id>
        <?supplied-pmid 31755899?>
        <pub-id pub-id-type="pmid">31755899</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yuan</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Testing and controlling for horizontal pleiotropy with probabilistic Mendelian randomization in transcriptome-wide association studies</article-title>
        <source>Nat. Commun.</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>3861</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-020-17668-6</pub-id>
        <?supplied-pmid 32737316?>
        <pub-id pub-id-type="pmid">32737316</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bulik-Sullivan</surname>
            <given-names>BK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>LD Score regression distinguishes confounding from polygenicity in genome-wide association studies</article-title>
        <source>Nat. Genet.</source>
        <year>2015</year>
        <volume>47</volume>
        <fpage>291</fpage>
        <lpage>295</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3211</pub-id>
        <?supplied-pmid 25642630?>
        <pub-id pub-id-type="pmid">25642630</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets</article-title>
        <source>Nat. Genet.</source>
        <year>2016</year>
        <volume>48</volume>
        <fpage>481</fpage>
        <lpage>487</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3538</pub-id>
        <?supplied-pmid 27019110?>
        <pub-id pub-id-type="pmid">27019110</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Tabix: fast retrieval of sequence features from generic TAB-delimited files</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <fpage>718</fpage>
        <lpage>719</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq671</pub-id>
        <?supplied-pmid 21208982?>
        <pub-id pub-id-type="pmid">21208982</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chang</surname>
            <given-names>CC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Second-generation PLINK: rising to the challenge of larger and richer datasets</article-title>
        <source>Gigascience</source>
        <year>2015</year>
        <volume>4</volume>
        <fpage>7</fpage>
        <pub-id pub-id-type="doi">10.1186/s13742-015-0047-8</pub-id>
        <?supplied-pmid 25722852?>
        <pub-id pub-id-type="pmid">25722852</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Keys</surname>
            <given-names>KL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>On the cross-population generalizability of gene expression prediction models</article-title>
        <source>PLoS Genet.</source>
        <year>2020</year>
        <volume>16</volume>
        <fpage>e1008927</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1008927</pub-id>
        <?supplied-pmid 32797036?>
        <pub-id pub-id-type="pmid">32797036</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Folkersen</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals</article-title>
        <source>Nat. Metab.</source>
        <year>2020</year>
        <volume>2</volume>
        <fpage>1135</fpage>
        <lpage>1148</lpage>
        <pub-id pub-id-type="doi">10.1038/s42255-020-00287-2</pub-id>
        <?supplied-pmid 33067605?>
        <pub-id pub-id-type="pmid">33067605</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Auton</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A global reference for human genetic variation</article-title>
        <source>Nature</source>
        <year>2015</year>
        <volume>526</volume>
        <fpage>68</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1038/nature15393</pub-id>
        <?supplied-pmid 26432245?>
        <pub-id pub-id-type="pmid">26432245</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lijoi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Prünster</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Walker</surname>
            <given-names>SG</given-names>
          </name>
        </person-group>
        <article-title>On consistency of nonparametric normal mixtures for Bayesian density estimation</article-title>
        <source>J. Am. Stat. Assoc.</source>
        <year>2005</year>
        <volume>100</volume>
        <fpage>1292</fpage>
        <lpage>1296</lpage>
        <pub-id pub-id-type="doi">10.1198/016214505000000358</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berisa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pickrell</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>Approximately independent linkage disequilibrium blocks in human populations</article-title>
        <source>Bioinformatics</source>
        <year>2016</year>
        <volume>32</volume>
        <fpage>283</fpage>
        <lpage>285</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btv546</pub-id>
        <?supplied-pmid 26395773?>
        <pub-id pub-id-type="pmid">26395773</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Robinson</surname>
            <given-names>GK</given-names>
          </name>
        </person-group>
        <article-title>That BLUP is a good thing: the estimation of random effects</article-title>
        <source>Stat. Sci.</source>
        <year>1991</year>
        <volume>6</volume>
        <fpage>15</fpage>
        <lpage>32</lpage>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hastie</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Regularization and variable selection via the elastic net</article-title>
        <source>J. R. Stat. Soc. Ser. B Stat. Methodol.</source>
        <year>2005</year>
        <volume>67</volume>
        <fpage>301</fpage>
        <lpage>320</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1467-9868.2005.00503.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Loh</surname>
            <given-names>P-R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Efficient Bayesian mixed-model analysis increases association power in large cohorts</article-title>
        <source>Nat. Genet.</source>
        <year>2015</year>
        <volume>47</volume>
        <fpage>284</fpage>
        <lpage>290</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3190</pub-id>
        <?supplied-pmid 25642633?>
        <pub-id pub-id-type="pmid">25642633</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
